N-CSRS 1 d788653dncsrs.htm GABELLI EQUITY TRUST INC. Gabelli Equity Trust Inc.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM N-CSR

CERTIFIED SHAREHOLDER REPORT OF REGISTERED MANAGEMENT

INVESTMENT COMPANIES

Investment Company Act file number            811-04700            

                         The Gabelli Equity Trust Inc.                        

(Exact name of registrant as specified in charter)

One Corporate Center

                                 Rye, New York 10580-1422                                

(Address of principal executive offices) (Zip code)

Bruce N. Alpert

Gabelli Funds, LLC

One Corporate Center

                           Rye, New York 10580-1422                        

(Name and address of agent for service)

Registrant’s telephone number, including area code:  1-800-422-3554

Date of fiscal year end:   December 31

Date of reporting period:  June 30, 2019

Form N-CSR is to be used by management investment companies to file reports with the Commission not later than 10 days after the transmission to stockholders of any report that is required to be transmitted to stockholders under Rule 30e-1 under the Investment Company Act of 1940 (17 CFR 270.30e-1). The Commission may use the information provided on Form N-CSR in its regulatory, disclosure review, inspection, and policymaking roles.

A registrant is required to disclose the information specified by Form N-CSR, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-CSR unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. § 3507.


Item 1. Reports to Stockholders.

The Report to Shareholders is attached herewith.


The Gabelli Equity Trust Inc.

Semiannual Report — June 30, 2019

To Our Shareholders,

For the six months ended June 30, 2019, the net asset value (NAV) total return of The Gabelli Equity Trust Inc. (the Fund) was 18.4%, compared with total returns of 18.5% and 15.4% for the Standard & Poor’s (S&P) 500 Index and the Dow Jones Industrial Average, respectively. The total return for the Fund’s publicly traded shares was 27.5%. The Fund’s NAV per share was $5.91, while the price of the publicly traded shares closed at $6.18 on the New York Stock Exchange (NYSE). See below for additional performance information.

Enclosed are the financial statements, including the schedule of investments, as of June 30, 2019.

Comparative Results

Average Annual Returns through June 30, 2019 (a) (Unaudited)

 
     Year to Date      1 Year      5 Year      10 Year      15 Year      20 Year      25 Year      Since
Inception
(08/21/86)
 

Gabelli Equity Trust

                       

NAV Total Return (b)

     18.43%            4.98%        6.87%        15.47%        9.70%        8.39%        10.12%        10.73%   

Investment Total Return (c)

     27.47               10.06           7.40           14.72           9.97           8.55           9.89           10.63      

S&P 500 Index

     18.54               10.42           10.71           14.70           8.75           5.90           9.97           10.22(d)  

Dow Jones Industrial Average

     15.36               12.14           12.24           14.97           9.14           7.02           10.83           11.20(d)  

Nasdaq Composite Index

     21.30               7.77           13.72           16.69           10.16           6.11           10.63           10.03(e)  

 

(a)   

Returns represent past performance and do not guarantee future results. Investment returns and the principal value of an investment will fluctuate. The Fund’s use of leverage may magnify the volatility of net asset value changes versus funds that do not employ leverage. When shares are sold, they may be worth more or less than their original cost. Current performance may be lower or higher than the performance data presented. Visit www.gabelli.com for performance information as of the most recent month end. Performance returns for periods of less than one year are not annualized. Investors should carefully consider the investment objectives, risks, charges, and expenses of the Fund before investing. The Dow Jones Industrial Average is an unmanaged index of 30 large capitalization stocks. The S&P 500 and the Nasdaq Composite Indices are unmanaged indicators of stock market performance. Dividends are considered reinvested except for the Nasdaq Composite Index. You cannot invest directly in an index.

(b)   

Total returns and average annual returns reflect changes in the NAV per share, reinvestment of distributions at NAV on the ex-dividend date, adjustments for rights offerings, spin-offs, and taxes paid on undistributed long term capital gains and are net of expenses. Since inception return is based on an initial NAV of $9.34.

(c)   

Total returns and average annual returns reflect changes in closing market values on the NYSE, reinvestment of distributions, and adjustments for rights offerings, spin-offs, and taxes paid on undistributed long term capital gains. Since inception return is based on an initial offering price of $10.00.

(d)   

From August 31, 1986, the date closest to the Fund’s inception for which data are available.

(e)   

From September 30, 1986, the date closest to the Fund’s inception for which data are available.

 

Beginning on January 1, 2021, as permitted by regulations adopted by the Securities and Exchange Commission, paper copies of the Fund’s annual and semiannual shareholder reports will no longer be sent by mail, unless you specifically request paper copies of the reports. Instead, the reports will be made available on the Fund’s website (www.gabelli.com), and you will be notified by mail each time a report is posted and provided with a website link to access the report. If you already elected to receive shareholder reports electronically, you will not be affected by this change and you need not take any action. To elect to receive all future reports on paper free of charge, please contact your financial intermediary, or, if you invest directly with the Fund, you may call 800-422-3554 or send an email request to info@gabelli.com.


Summary of Portfolio Holdings (Unaudited)

The following table presents portfolio holdings as a percent of total investments as of June 30, 2019:

The Gabelli Equity Trust Inc.

 

Food and Beverage

     11.9

Financial Services

     10.1

Equipment and Supplies

     7.3

Diversified Industrial

     5.3

Health Care

     5.2

Entertainment

     5.0

Consumer Services

     4.6

Business Services

     4.6

Consumer Products

     3.8

Energy and Utilities

     3.6

Cable and Satellite

     3.6

Automotive: Parts and Accessories

     3.5

Broadcasting

     3.0

Aerospace and Defense

     2.8

Machinery

     2.7

Telecommunications

     2.6

Electronics

     2.5

Retail

     2.3

Specialty Chemicals

     2.0

Environmental Services

     2.0

Hotels and Gaming

     1.9

Aviation: Parts and Services

     1.5

Building and Construction

     1.0

Wireless Communications

     0.9

Computer Software and Services

     0.8

Automotive

     0.8

Closed-End Funds

     0.7

U.S. Government Obligations

     0.7

Metals and Mining

     0.6

Transportation

     0.5

Communications Equipment

     0.5

Publishing

     0.5

Real Estate

     0.5

Agriculture

     0.5

Manufactured Housing and Recreational Vehicles

     0.2
  

 

 

 
     100.0
  

 

 

 
 

 

The Fund files a complete schedule of portfolio holdings with the Securities and Exchange Commission (the SEC) for the first and third quarters of each fiscal year on Form N-PORT. Shareholders may obtain this information at www.gabelli.com or by calling the Fund at 800-GABELLI (800-422-3554). The Fund’s Form N-PORT is available on the SEC’s website at www.sec.gov and may also be reviewed and copied at the SEC’s Public Reference Room in Washington, DC. Information on the operation of the Public Reference Room may be obtained by calling 800-SEC-0330.

Proxy Voting

The Fund files Form N-PX with its complete proxy voting record for the twelve months ended June 30, no later than August 31 of each year. A description of the Fund’s proxy voting policies, procedures, and how the Fund voted proxies relating to portfolio securities is available without charge, upon request, by (i) calling 800-GABELLI (800-422-3554); (ii) writing to The Gabelli Funds at One Corporate Center, Rye, NY 10580-1422; or (iii) visiting the SEC’s website at www.sec.gov.

 

We have separated the portfolio managers’ commentary from the financial statements and investment portfolio due to corporate governance regulations stipulated by the Sarbanes-Oxley Act of 2002. We have done this to ensure that the content of the portfolio managers’ commentary is unrestricted. Both the commentary and the financial statements, including the portfolio of investments, will be available on our website at www.gabelli.com.

 

2


The Gabelli Equity Trust Inc.

Portfolio Changes — Six Months Ended June 30, 2019 (Unaudited)

 

 

 

     Shares      Ownership at
June 30,
2019
 

NET PURCHASES

     

Common Stocks

     

Acorda Therapeutics Inc.

     2,500          10,411    

Alcon Inc.

     16,200          16,200    

Alkermes plc

     2,000          2,000    

Alnylam Pharmaceuticals Inc.

     5,500          7,500    

Aptinyx Inc.

     15,901          15,901    

Ardagh Group SA

     4,000          4,000    

Armstrong Flooring Inc.

     38,210          78,210    

Astec Industries Inc.

     7,000          25,000    

Axogen Inc.

     9,600          9,600    

Axovant Gene Therapies Ltd.(a)

     2,596          2,596    

Bank of America Corp.

     30,000          90,000    

BioTelemetry Inc.

     8,000          8,000    

Bristol-Myers Squibb Co.

     8,700          155,000    

CBS Corp., Cl. A, Voting

     10,700          251,000    

CBS Corp., Cl. B, Non-Voting

     10,000          20,000    

CenturyLink Inc.

     14,750          50,000    

Clear Channel Outdoor Holdings Inc.

     180,035          180,035    

Clovis Oncology Inc.

     16,500          31,400    

Colfax Corp.

     25,000          25,000    

Comcast Corp., Cl. A

     19,000          193,000    

Conagra Brands Inc.

     90,000          265,000    

Corteva Inc.(b)

     15,000          15,000    

Covetrus Inc.(c)

     69,000          69,000    

CytomX Therapeutics Inc.

     6,000          6,000    

Dana Inc.

     9,000          240,900    

Dover Motorsports Inc.

     418,000          418,000    

Dow Inc.(b)

     28,333          28,333    

DuPont de Nemours Inc.(b)

     38,333          38,333    

EchoStar Corp., Cl. A

     9,000          48,933    

Edgewell Personal Care Co.

     31,000          205,000    

Editas Medicine Inc.

     1,000          2,000    

Energizer Holdings Inc.

     28,000          167,000    

EnPro Industries Inc.

     10,000          10,000    

Ensco Rowan plc, Cl. A

     79,062          79,062    

Entercom Communications Corp., Cl. A

     70,000          500,000    

Evoqua Water Technologies Corp.

     2,296          2,296    

Flowserve Corp.

     30,000          252,000    

Fox Corp., Cl. A

     161,733          161,733    

Fox Corp., Cl. B

     134,999          134,999    

G1 Therapeutics Inc.

     2,000          2,000    

GAM Holding AG

     10,000          30,000    

GCP Applied Technologies Inc.

     61,500          61,500    

Globus Medical Inc., Cl. A

     1,000          1,000    

Gritstone Oncology Inc.

     6,000          6,000    

Grupo Televisa SAB, ADR

     70,000          586,000    

Halliburton Co.

     45,000          251,700    

Herc Holdings Inc.

     53,676          210,235    

Inogen Inc.

     6,900          6,900    

Internap Corp.

     264,999          515,874    

IRIDEX Corp.

     5,000          10,000    
     Shares      Ownership at
June 30,
2019
 

KLX Energy Services Holdings Inc.

     11,000          60,615    

L3Harris Technologies Inc.

     15,001          15,001    

LivaNova plc

     1,000          1,000    

Livent Corp.(d)

     9,353          9,353    

Lowe’s Companies Inc.

     5,000          34,000    

Mallinckrodt plc

     1,000          10,500    

Marinus Pharmaceuticals Inc.

     10,000          27,000    

Matthews International Corp., Cl. A

     11,000          18,000    

Meridian Bioscience Inc.

     1,500          5,500    

MGM Resorts International

     86,000          236,000    

Molson Coors Brewing Co., Cl. B

     10,000          60,000    

MSG Networks Inc., Cl. A

     3,000          282,600    

Mueller Water Products Inc., Cl. A

     70,000          300,000    

Mylan NV

     6,000          6,000    

Myriad Genetics Inc.

     3,000          4,000    

Neuronetics Inc.

     9,500          9,500    

New York Community Bancorp Inc.

     80,000          80,000    

Newell Brands Inc.

     65,000          65,000    

Nuvectra Corp.

     3,000          3,000    

PetMed Express Inc.

     7,000          16,800    

PGT Innovations Inc.

     40,000          40,000    

Phillips 66

     10,000          42,100    

Puma Biotechnology Inc.

     1,500          8,500    

Rayonier Advanced Materials Inc.

     334          10,000    

Resideo Technologies Inc.

     35,000          110,334    

Retrophin Inc.

     2,000          2,000    

ReWalk Robotics Ltd.

     27,064          27,064    

Rockwell Medical Inc.

     16,121          16,121    

Rolls-Royce Holdings plc, Cl. C(e)

     85,839,000          85,839,000    

Sinclair Broadcast Group Inc., Cl. A

     4,500          4,500    

T2 Biosystems Inc.

     13,000          13,000    

Take-Two Interactive Software Inc.

     8,000          8,000    

Teva Pharmaceutical Industries Ltd., ADR

     5,000          13,000    

Textron Inc.

     10,600          84,000    

The Blackstone Group Inc., Cl. A

     28,000          28,000    

The PNC Financial Services Group Inc.

     7,000          17,000    

The Walt Disney Co.

     103,000          103,000    

Tootsie Roll Industries Inc.(f)

     3,570          138,500    

United Therapeutics Corp.

     1,300          5,000    

USANA Health Sciences Inc.

     3,400          3,400    

Valeritas Holdings Inc.(g)

     11,996          11,996    

Viacom Inc., Cl. B

     5,000          5,000    

Vodafone Group plc, ADR

     21,973          70,000    

W. R. Berkley Corp.(h)

     2,500          15,500    

Walgreens Boots Alliance Inc.

     2,000          64,000    

Weatherford International plc

     450,000          712,300    

Weight Watchers International Inc.

     3,000          9,500    

William Hill plc

     200,000          200,000    

Zafgen Inc.

     22,000          22,000    

Zayo Group Holdings Inc.

     10,000          30,000    

Zomedica Pharmaceuticals Corp.

     8,688          8,688    
 

 

See accompanying notes to financial statements.

 

3


The Gabelli Equity Trust Inc.

Portfolio Changes (Continued) — Six Months Ended June 30, 2019 (Unaudited)

 

 

 

    Shares     Ownership at
June 30,
2019
 

Rights

   

Hertz Global Holdings Inc., expire
07/12/2019(i)

    210,000         210,000    

NET SALES

   

Common Stocks

   

ACADIA Pharmaceuticals Inc.

    (3,000)         6,500    

Achaogen Inc.

    (191,000)         -    

Adient plc

    (7,162)         8,000    

Alexion Pharmaceuticals Inc.

    (3,500)         -    

Allergan plc

    (6,300)         14,300    

Alphabet Inc., Cl. C

    (500)         3,000    

American Express Co.

    (5,000)         345,000    

AmerisourceBergen Corp.

    (4,700)         20,000    

AMETEK Inc.

    (5,000)         398,000    

Ampco-Pittsburgh Corp.

    (3,227)         160,000    

Anadarko Petroleum Corp.

    (12,000)         27,000    

Anika Therapeutics Inc.

    (6,000)         -    

Apache Corp.

    (9,000)         50,000    

Apple Inc.

    (1,000)         4,000    

Arconic Inc.

    (11,666)         30,000    

Argo Group International Holdings Ltd.

    (698)         16,000    

AT&T Inc.

    (143,740)         108,452    

Avon Products Inc.

    (60,000)         100,000    

Axovant Sciences Ltd.(a)

    (20,771)         -    

Barrick Gold Corp.

    (4,000)         50,000    

Bausch Health Cos. Inc.

    (4,000)         1,000    

Belmond Ltd., Cl. A

    (49,000)         -    

Biogen Inc.

    (2,200)         7,000    

BioScrip Inc.

    (167,368)         2,766,451    

Blucora Inc.

    (2,000)         13,000    

Bluebird Bio Inc.

    (1,500)         -    

BorgWarner Inc.

    (14,000)         93,600    

Boston Scientific Corp.

    (40,000)         210,000    

Cardiovascular Systems Inc.

    (3,000)         -    

Charter Communications Inc., Cl. A

    (3,000)         26,358    

Check Point Software Technologies Ltd.

    (500)         5,500    

Cincinnati Bell Inc.

    (20,000)         73,000    

CIRCOR International Inc.

    (11,409)         127,591    

Citigroup Inc.

    (2,000)         97,000    

Clear Channel Outdoor Holdings Inc., Cl. A

    (180,035)         -    

ConocoPhillips

    (5,000)         172,000    

Corning Inc.

    (10,000)         275,000    

Coty Inc., Cl. A

    (45,600)         -    

CRISPR Therapeutics AG

    (1,000)         1,000    

Cullen/Frost Bankers Inc.

    (4,000)         5,000    

Curtiss-Wright Corp.

    (1,500)         223,300    

Cutera Inc.

    (1,000)         17,900    

CVS Health Corp.

    (19,000)         85,000    

Danone SA

    (5,000)         196,500    

Deere & Co.

    (5,000)         175,000    

Demant A/S

    (6,000)         244,000    
     Shares      Ownership at
June 30,
2019
 

Diebold Nixdorf Inc.

     (82,290)          228,000    

DISH Network Corp., Cl. A

     (59,500)          100,400    

Donnelley Financial Solutions, Inc.

     (25,000)          -    

DowDuPont Inc.(b)

     (105,000)          -    

El Paso Electric Co.

     (4,000)          200,000    

Energy Transfer LP

     (7,000)          55,000    

Evergy Inc.

     (22,000)          20,000    

Evolus Inc.

     (500)          4,500    

First Data Corp., Cl. A

     (20,000)          40,000    

frontdoor Inc.

     (2,500)          -    

GCI Liberty Inc., Cl. A

     (5,000)          78,935    

General Electric Co.(j)

     (20,000)          220,000    

GenOn Energy Inc., Escrow

     (140,000)          -    

Genuine Parts Co.

     (1,000)          248,200    

Gogo Inc.

     (155,409)          304,282    

Granite Construction Inc.

     (12,150)          -    

Griffon Corp.

     (4,942)          75,000    

Groupon Inc.

     (125,000)          225,000    

H&R Block Inc.

     (13,000)          50,000    

H.B. Fuller Co.

     (7,000)          24,000    

Hanesbrands Inc.

     (5,000)          85,000    

Harris Corp.

     (32,001)          -    

Hertz Global Holdings Inc.(k)

     (10,000)          210,000    

Hewlett Packard Enterprise Co.

     (10,000)          240,000    

Honeywell International Inc.

     (4,000)          294,000    

IDEX Corp.

     (1,000)          209,000    

Incyte Corp.

     (1,900)          6,500    

International Flavors & Fragrances Inc.

     (2,000)          53,000    

InterXion Holding NV

     (1,000)          22,000    

J.C. Penney Co. Inc.

     (40,000)          60,000    

Janus Henderson Group plc

     (20,000)          80,000    

Johnson Controls International plc

     (55,814)          272,528    

Kerry Group plc, Cl. A

     (1,400)          62,100    

Keurig Dr Pepper Inc.

     (30,000)          72,400    

Legg Mason Inc.

     (5,000)          140,000    

LeMaitre Vascular Inc.

     (1,000)          600    

Lennar Corp., Cl. A

     (20,000)          17,500    

Liberty Broadband Corp., Cl. C

     (1,000)          62,192    

Liberty Global plc, Cl. C

     (16,829)          326,064    

Liberty Media Corp.-
Liberty Formula One, Cl. A

     (1,200)          88,050    

Lions Gate Entertainment Corp., Cl. B

     (2,096)          46,545    

Macy’s Inc.

     (7,000)          295,000    

Marriott Vacations Worldwide Corp.

     (1,600)          2,000    

Mastercard Inc., Cl. A

     (9,500)          244,500    

Mattel Inc.

     (5,000)          20,000    

McKesson Corp.

     (1,000)          -    

Mondelēz International Inc., Cl. A

     (25,000)          340,000    

National Presto Industries Inc.

     (500)          10,500    

Natus Medical Inc.

     (573)          2,427    

NeoGenomics Inc.

     (8,602)          -    

Nevro Corp.

     (10,500)          3,000    
 

 

See accompanying notes to financial statements.

 

4


The Gabelli Equity Trust Inc.

Portfolio Changes (Continued) — Six Months Ended June 30, 2019 (Unaudited)

 

 

 

     Shares      Ownership at
June 30,
2019
 

Novartis AG, ADR(l)

     (1,000)          83,000    

NuVasive Inc.

     (1,600)          4,400    

Och-Ziff Capital Management Group Inc., Cl. A(i)

     (40,500)          4,500    

O’Reilly Automotive Inc.

     (10,000)          60,000    

Patterson-UTI Energy Inc.

     (27,500)          107,500    

Penske Automotive Group Inc.

     (3,000)          7,000    

PepsiCo Inc.

     (2,000)          158,000    

PetIQ Inc.

     (7,000)          43,000    

Qurate Retail Inc.

     (10,000)          241,265    

Reading International Inc., Cl. A

     (4,000)          10,000    

Replimune Group Inc.

     (5,000)          -    

Rite Aid Corp.(m)

     (50,000)          -    

Rollins Inc.

     (20,000)          1,885,000    

Rolls-Royce Holdings plc, Cl. C

     (55,614,000)          -    

Rowan Companies plc, Cl. A

     (115,000)          -    

RPC Inc.

     (65,805)          32,680    

Sensient Technologies Corp.

     (21,000)          144,800    

SGL Carbon SE

     (1,000)          17,000    

SunTrust Banks Inc.

     (2,000)          15,000    

Superior Industries International Inc.

     (5,000)          68,000    

Tandem Diabetes Care Inc.

     (6,000)          2,135    

Telephone & Data Systems Inc.

     (10,000)          553,700    

TESARO Inc.

     (2,400)          -    

Texas Instruments Inc.

     (6,000)          227,000    

The Blackstone Group LP

     (25,000)          -    

The Boeing Co.

     (1,000)          34,000    

The Coca-Cola Co.

     (10,000)          89,600    

The Dun & Bradstreet Corp.

     (12,300)          -    

The Hain Celestial Group Inc.

     (55,426)          72,000    

The Interpublic Group of Companies Inc.

     (20,000)          260,000    

The Kraft Heinz Co.

     (40,000)          45,000    

The Madison Square Garden Co., Cl. A

     (300)          103,867    

TimkenSteel Corp.

     (15,000)          200,000    

Tribune Media Co., Cl. A

     (27,000)          3,000    

Twenty-First Century Fox Inc., Cl. A

     (485,200)          -    

Twenty-First Century Fox Inc., Cl. B

     (405,000)          -    

UnitedHealth Group Inc.

     (2,000)          47,000    

Waste Management Inc.

     (8,000)          145,600    

Watts Water Technologies Inc., Cl. A

     (5,000)          126,000    

Weyerhaeuser Co., REIT

     (5,000)          15,000    

Xylem Inc.

     (12,000)          220,000    

Zimmer Biomet Holdings Inc.

     (5,500)          13,500    
     Shares      Ownership at
June 30,
2019
 

Zoetis Inc.

     (3,000)          32,000    

Rights

     

Ladbrokes plc, CVR

     (579,400)          -    

 

 

(a)

Reverse Split - 1 New share of Axovant Gene Therapies Ltd. (BK5H4W5) for every 8 old shares of Axovant Sciences Ltd. (BYYT6W4) held.

(b)

Spin-off - 0.3333 new shares of Dupont De Nemours (26614N102) plus 0.3333 new share of Corteva Inc. (22052L104) for every 3 shares of Dow Dupont Inc. 23,333 shares of Corteva Inc. were sold after the spin-off. Spin-off- 1 Dow Inc. (260557103) for every 3 shares of DuPont De Nemours Inc. (26078J100) held.

(c)

Spin-off- 2 New Covetrus Inc. (22304C100) shares for every 5 shares of Henry Schein Inc.(806407102) held. 44,600 shares of Covetrus Inc. were purchased after the spin-off.

(d)

Spin-off - 0.935301 new share of Livent Corp. (53814L108) for every 1share of FMC Corp. (302491303) held.

(e)

Bonus Issue of Shares - 71 New Rolls-Royce Holdings plc, Cl. C (BJ02V94) for every 1 Rolls-Royce Holdings plc. (B63H849) common share held.

(f)

Stock dividend - 0.03 shares for every 1 share held.

(g)

Stock Split - 1 New share of Valeritas Holdings Inc. (91914N301) for every 20 old shares of Valeritas Holdings Inc. (91914N202) held. 8,000 shares were purchased after stock split.

(h)

Stock Split - 3 New shares of W. R. Berkley Corp. (084423102) for every 2 old shares held.

(i)

Reverse Split - 0.10 New share of Och-Ziff Capital Management Group LLC, Cl. A (67551U204) for every 1 share of Och-Ziff Capital Management Group Inc., Cl. A.

(j)

Spin-off- 0.005371 Westinghouse Air Brake Technologies Corp. (929740108) share for every 1 share of General Electric Co. (369604103) held. 240,000 shares of General Electric Co. were purchased and 20,000 shares were sold after the spin-off.

(k)

Rights Offering - 1 Hertz Global Holdings Inc. expire 07/12/2019 (42806J114) right for every 1 share of Hertz Global Holdings Inc. (42806J106) held.0.688285 Hertz Global Holdings Inc. (42806J106) shares for every 1 right exercised.

(l)

Spin-off- 1 New Alcon Inc.(BJXBP41) share for every 5 shares of Novartis AG, ADR (66987V109) held.

(m)

Consolidation of Shares - 1 New share of Rite Aid Corp. (767754872) for every 20 old shares of Rite Aid Corp. (767754104) held. 2,500 shares of Rite Aid Corp. were sold after consolidation.

 

 

See accompanying notes to financial statements.

 

5


The Gabelli Equity Trust Inc.

Schedule of Investments — June 30, 2019 (Unaudited)

 

 

 

Shares

       

Cost

   

Market
Value

 
  COMMON STOCKS — 98.6%

 

 
  Food and Beverage — 11.9%

 

 
  3,000    

Ajinomoto Co. Inc.

  $ 52,866     $ 51,978  
  105,200    

Brown-Forman Corp.,
Cl. A

    1,456,472       5,786,000  
  49,300    

Brown-Forman Corp.,
Cl. B

    1,130,138       2,732,699  
  63,800    

Campbell Soup Co.

    1,781,130       2,556,466  
  65,000    

Chr. Hansen Holding A/S

    2,725,303       6,103,761  
  15,000    

Coca-Cola European Partners plc

    275,290       847,500  
  265,000    

Conagra Brands Inc.

    7,421,799       7,027,800  
  30,000    

Constellation Brands Inc., Cl. A

    376,266       5,908,200  
  18,000    

Crimson Wine Group Ltd.†

    91,848       144,000  
  196,500    

Danone SA

    9,534,322       16,646,294  
  1,277,600    

Davide Campari-Milano SpA

    3,498,059       12,515,520  
  127,000    

Diageo plc, ADR

    11,895,752       21,884,640  
  80,000    

Flowers Foods Inc.

    263,976       1,861,600  
  77,800    

Fomento Economico Mexicano SAB de CV, ADR

    3,108,750       7,527,150  
  40,000    

General Mills Inc.

    1,885,325       2,100,800  
  1,848,400    

Grupo Bimbo SAB de CV, Cl. A

    2,624,248       3,853,050  
  41,300    

Heineken NV

    1,962,995       4,608,874  
  11,000    

Ingredion Inc.

    162,440       907,390  
  105,000    

ITO EN Ltd.

    2,422,898       4,888,930  
  27,000    

Kellogg Co.

    1,489,530       1,446,390  
  62,100    

Kerry Group plc, Cl. A

    714,019       7,414,462  
  72,400    

Keurig Dr Pepper Inc.

    2,391,750       2,092,360  
  50,000    

Lamb Weston Holdings Inc.

    1,785,039       3,168,000  
  9,700    

LVMH Moet Hennessy Louis Vuitton SE

    335,341       4,128,481  
  20,000    

Maple Leaf Foods Inc.

    365,417       438,013  
  60,000    

Molson Coors Brewing Co., Cl. B

    3,751,665       3,360,000  
  340,000    

Mondelēz International Inc., Cl. A

    12,710,555       18,326,000  
  14,000    

Morinaga Milk Industry Co. Ltd.

    299,202       553,819  
  41,000    

Nestlé SA

    1,791,828       4,244,479  
  158,000    

PepsiCo Inc.

    13,389,123       20,718,540  
  39,200    

Pernod Ricard SA

    3,228,300       7,223,270  
  31,000    

Post Holdings Inc.†

    2,232,792       3,223,070  
  41,500    

Remy Cointreau SA

    2,589,709       5,983,649  
  89,600    

The Coca-Cola Co.

    2,869,378       4,562,432  
  72,000    

The Hain Celestial Group Inc.†

    1,817,602       1,576,800  
  18,500    

The J.M. Smucker Co.

    1,791,781       2,131,015  
  45,000    

The Kraft Heinz Co.

    2,906,089       1,396,800  
  138,500    

Tootsie Roll Industries Inc.

    1,751,708       5,114,805  
  48,000    

Tyson Foods Inc., Cl. A

    397,211       3,875,520  
  341,000    

Yakult Honsha Co. Ltd.

    9,700,538       20,083,940  
   

 

 

   

 

 

 
          120,978,454           229,014,497  
   

 

 

   

 

 

 

Shares

       

Cost

   

Market

Value

 
  Financial Services — 10.1%

 

 
  345,000    

American Express Co.(a)

  $ 28,856,296     $ 42,586,800  
  25,000    

American International Group Inc.

    1,374,505       1,332,000  
  16,000    

Argo Group International Holdings Ltd.

    371,865       1,184,800  
  72,585    

Banco Santander SA, ADR

    548,401       332,439  
  90,000    

Bank of America Corp.

    2,725,874       2,610,000  
  113    

Berkshire Hathaway Inc.,
Cl. A†

    332,448       35,973,550  
  11,000    

CIT Group Inc.

    479,878       577,940  
  97,000    

Citigroup Inc.

    4,841,366       6,792,910  
  5,000    

Cullen/Frost Bankers Inc.

    361,440       468,300  
  30,000    

Deutsche Bank AG

    778,621       228,900  
  30,000    

Fidelity National Financial Inc.

    1,064,754       1,209,000  
  30,000    

GAM Holding AG†

    212,026       138,660  
  50,000    

H&R Block Inc.

    1,217,976       1,465,000  
  5,000    

I3 Verticals Inc., Cl. A†

    75,042       147,250  
  40,000    

Interactive Brokers Group Inc., Cl. A

    643,310       2,168,000  
  80,000    

Janus Henderson Group plc

    2,514,621       1,712,000  
  88,000    

Jefferies Financial Group Inc

    1,259,355       1,692,240  
  61,400    

JPMorgan Chase & Co.

    3,250,397       6,864,520  
  29,800    

Kinnevik AB, Cl. A

    494,015       810,293  
  140,000    

Legg Mason Inc.

    4,025,995       5,359,200  
  14,000    

Loews Corp.

    558,454       765,380  
  100,000    

Marsh & McLennan Companies Inc.

    4,026,856       9,975,000  
  9,000    

Moody’s Corp.

    312,150       1,757,790  
  80,000    

New York Community Bancorp Inc.

    899,228       798,400  
  4,500    

Och-Ziff Capital Management Group Inc., Cl. A

    90,116       103,320  
  20,000    

PayPal Holdings Inc.†

    651,955       2,289,200  
  62,000    

S&P Global Inc.

    3,545,109       14,122,980  
  161,100    

State Street Corp.

    8,115,787       9,031,266  
  15,000    

SunTrust Banks Inc.

    316,604       942,750  
  112,400    

T. Rowe Price Group Inc.

    6,592,342       12,331,404  
  28,000    

The Blackstone Group Inc., Cl. A

    984,750       1,243,760  
  212,500    

The Bank of New York Mellon Corp.

    6,816,744       9,381,875  
  20,000    

The Charles Schwab Corp.

    292,250       803,800  
  17,000    

The PNC Financial Services Group Inc.

    1,867,763       2,333,760  
  3,000    

TransUnion

    128,898       220,530  
  15,500    

W. R. Berkley Corp.

    380,920       1,021,915  
  170,000    

Waddell & Reed Financial Inc., Cl. A

    3,871,168       2,833,900  
  230,000    

Wells Fargo & Co.

    7,227,021       10,883,600  
   

 

 

   

 

 

 
          102,106,300           194,494,432  
   

 

 

   

 

 

 
 

 

See accompanying notes to financial statements.

 

6


The Gabelli Equity Trust Inc.

Schedule of Investments (Continued) — June 30, 2019 (Unaudited)

 

 

Shares

       

Cost

   

Market

Value

 
  COMMON STOCKS (Continued)

 

 
  Equipment and Supplies — 7.3%

 

 
  398,000    

AMETEK Inc.

  $ 15,413,644     $ 36,154,320  
  7,000    

Amphenol Corp., Cl. A

    12,928       671,580  
  4,000    

Ardagh Group SA

    59,723       70,000  
  127,591    

CIRCOR International Inc.†

    4,548,457       5,869,186  
  325,800    

Donaldson Co. Inc.

    7,692,826       16,570,188  
  252,000    

Flowserve Corp.

    7,492,973       13,277,880  
  37,400    

Franklin Electric Co. Inc.

    215,706       1,776,500  
  209,000    

IDEX Corp.

    16,292,608       35,977,260  
  43,000    

Ingersoll-Rand plc

    928,418       5,446,810  
  100,000    

Mueller Industries Inc.

    2,565,501       2,927,000  
  300,000    

Mueller Water Products Inc., Cl. A

    3,282,173       2,946,000  
  13,000    

Sealed Air Corp.

    208,280       556,140  
  45,000    

Tenaris SA, ADR

    1,981,220       1,183,950  
  80,000    

The Timken Co.

    3,018,718       4,107,200  
  59,600    

The Weir Group plc

    250,790       1,170,535  
  126,000    

Watts Water Technologies Inc., Cl. A

    5,663,744       11,740,680  
  4,000    

Welbilt Inc.†

    19,596       66,800  
   

 

 

   

 

 

 
          69,647,305           140,512,029  
   

 

 

   

 

 

 
  Diversified Industrial — 5.3%

 

 
  8,000    

Acuity Brands Inc.

    1,045,758       1,103,280  
  160,000    

Ampco-Pittsburgh Corp.†

    2,097,308       644,800  
  25,000    

Colfax Corp.†

    623,949       700,750  
  170,100    

Crane Co.

    8,699,432       14,193,144  
  10,000    

EnPro Industries Inc.

    650,376       638,400  
  220,000    

General Electric Co.

    2,518,628       2,310,000  
  15,000    

Graf Industrial Corp.†

    150,000       153,525  
  127,000    

Greif Inc., Cl. A

    2,692,735       4,133,850  
  12,000    

Greif Inc., Cl. B

    727,946       523,800  
  75,000    

Griffon Corp.

    1,445,882       1,269,000  
  294,000    

Honeywell International Inc.

    28,450,838       51,329,460  
  3,500    

IntriCon Corp.†

    82,415       81,760  
  97,000    

ITT Inc.

    2,136,880       6,351,560  
  11,000    

Jardine Strategic Holdings Ltd.

    222,951       419,430  
  40,000    

Kennametal Inc.

    895,654       1,479,600  
  50,000    

Myers Industries Inc.

    818,952       963,500  
  35,000    

nVent Electric plc

    381,839       867,650  
  85,000    

Park-Ohio Holdings Corp.

    892,930       2,770,150  
  10,000    

Rayonier Advanced Materials Inc.

    156,631       64,900  
  30,000    

Rexnord Corp.†

    630,867       906,600  
  50,000    

Schultze Special Purpose Acquisition Corp.†

    500,000       509,000  
  31,000    

ServiceMaster Global Holdings Inc.†

    959,380       1,614,790  
  11,500    

Sulzer AG

    592,231       1,256,966  
  84,000    

Textron Inc.

    4,768,750       4,455,360  
  100,000    

Toray Industries Inc.

    771,663       759,820  

Shares

       

Cost

   

Market

Value

 
  12,000    

Tredegar Corp.

  $ 171,530     $ 199,440  
  85,000    

Trinity Industries Inc.

    1,397,210       1,763,750  
   

 

 

   

 

 

 
          64,482,735           101,464,285  
   

 

 

   

 

 

 
  Health Care — 5.2%

 

 
  6,500    

ACADIA Pharmaceuticals Inc.†

    99,377       173,745  
  10,411    

Acorda Therapeutics Inc.†

    186,064       79,852  
  1,000    

Aerie Pharmaceuticals Inc.†

    34,020       29,550  
  20,000    

Akorn Inc.†

    110,205       103,000  
  16,200    

Alcon Inc.†

    574,003       1,005,210  
  2,000    

Alkermes plc†

    48,540       45,080  
  14,300    

Allergan plc

    2,042,780       2,394,249  
  7,500    

Alnylam Pharmaceuticals Inc.†

    555,248       544,200  
  20,000    

AmerisourceBergen Corp.

    1,673,215       1,705,200  
  32,000    

Amgen Inc.

    2,587,279       5,896,960  
  1,000    

AngioDynamics Inc.†

    19,005       19,690  
  15,901    

Aptinyx Inc.†

    64,622       53,109  
  1,500    

Arena Pharmaceuticals Inc.†

    50,630       87,945  
  2,200    

AtriCure Inc.†

    36,243       65,648  
  9,600    

Axogen Inc.†

    159,542       190,080  
  2,596    

Axovant Gene Therapies Ltd.†

    46,529       16,173  
  1,000    

Bausch Health Cos. Inc.†

    21,780       25,220  
  13,000    

Baxter International Inc.

    400,407       1,064,700  
  7,000    

Biogen Inc.†

    1,589,856       1,637,090  
  1,500    

BioMarin Pharmaceutical Inc.†

    118,526       128,475  
  2,766,451    

BioScrip Inc.†

    5,713,103       7,192,773  
  8,000    

BioTelemetry Inc.†

    388,910       385,200  
  210,000    

Boston Scientific Corp.†

    5,456,988       9,025,800  
  155,000    

Bristol-Myers Squibb Co.

    8,261,043       7,029,250  
  1,500    

Celgene Corp.†

    98,030       138,660  
  4,868    

Cigna Corp.

    937,667       766,953  
  31,400    

Clovis Oncology Inc.†

    808,111       466,918  
  104,056    

ConforMIS Inc.†

    142,681       453,684  
  69,000    

Covetrus Inc.†

    1,800,404       1,687,740  
  1,000    

CRISPR Therapeutics AG†

    23,870       47,100  
  17,900    

Cutera Inc.†

    507,699       371,962  
  6,000    

CytomX Therapeutics Inc.†

    60,611       67,320  
  244,000    

Demant A/S†

    2,221,329       7,586,725  
  6,000    

Dermira Inc.†

    56,600       57,360  
  2,000    

Editas Medicine Inc.†

    41,140       49,480  
  2,000    

ElectroCore Inc.†

    28,040       4,000  
  25,267    

Electromed Inc.†

    128,953       137,705  
  17,200    

Endo International plc†

    127,782       70,864  
  4,500    

Evolus Inc.†

    71,374       65,790  
  2,000    

G1 Therapeutics Inc.†

    29,540       61,320  
  10,370    

GenMark Diagnostics Inc.†

    44,815       67,301  
  1,000    

Globus Medical Inc., Cl. A†

    40,696       42,300  
  6,000    

Gritstone Oncology Inc.†

    65,168       66,840  
  61,000    

Henry Schein Inc.†

    1,700,084       4,263,900  
 

 

See accompanying notes to financial statements.

 

7


The Gabelli Equity Trust Inc.

Schedule of Investments (Continued) — June 30, 2019 (Unaudited)

 

 

Shares

       

Cost

   

Market
Value

 
  COMMON STOCKS (Continued)

 

 
  Health Care (Continued)

 

 
  500    

ICU Medical Inc.†

  $ 107,502     $ 125,955  
  6,500    

Incyte Corp.†

    617,516       552,240  
  46,800    

Indivior plc†

    28,408       25,360  
  6,900    

Inogen Inc.†

    528,058       460,644  
  2,000    

Intellia Therapeutics Inc.†

    25,140       32,740  
  10,000    

IRIDEX Corp.†

    46,648       45,500  
  37,000    

Johnson & Johnson

    2,596,768       5,153,360  
  7,000    

Jounce Therapeutics Inc.†

    54,040       34,650  
  28,323    

Lannett Co. Inc.†

    264,804       171,637  
  600    

LeMaitre Vascular Inc.

    17,412       16,788  
  1,000    

LivaNova plc†

    68,730       71,960  
  10,500    

Mallinckrodt plc†

    149,520       96,390  
  27,000    

Marinus Pharmaceuticals Inc.†

    123,443       112,050  
  105,200    

Merck & Co. Inc.

        5,251,624       8,821,020  
  5,500    

Meridian Bioscience Inc.

    79,650       65,340  
  6,000    

Mylan NV†

    126,780       114,240  
  4,000    

Myriad Genetics Inc.†

    108,830       111,120  
  17,559    

Nabriva Therapeutics plc†

    47,240       42,668  
  2,427    

Natus Medical Inc.†

    65,947       62,350  
  5,000    

Nektar Therapeutics†

    236,762       177,900  
  9,500    

Neuronetics Inc.†

    125,865       118,845  
  3,000    

Nevro Corp.†

    111,190       194,490  
  83,000    

Novartis AG, ADR

    4,261,417           7,578,730  
  4,400    

NuVasive Inc.†

    214,420       257,576  
  3,000    

Nuvectra Corp.†

    27,260       10,050  
  2,000    

Orthofix Medical Inc.†

    103,329       105,760  
  9,859    

Patterson Cos. Inc.

    231,487       225,771  
  1,000    

Perrigo Co. plc

    38,520       47,620  
  8,500    

Puma Biotechnology Inc.†

    198,918       108,035  
  1,037    

Ra Pharmaceuticals Inc.†

    6,200       31,183  
  500    

Regeneron Pharmaceuticals Inc.†

    159,786       156,500  
  2,000    

Retrophin Inc.†

    37,040       40,180  
  27,064    

ReWalk Robotics Ltd.†

    94,116       117,728  
  16,121    

Rockwell Medical Inc.†

    54,685       48,524  
  3,000    

Sangamo Therapeutics Inc.†

    39,060       32,310  
  5,500    

Sol-Gel Technologies Ltd.†

    33,500       50,077  
  13,000    

T2 Biosystems Inc.†

    35,660       21,840  
  2,135    

Tandem Diabetes Care Inc.†

    5,380       137,750  
  13,000    

Teva Pharmaceutical Industries Ltd., ADR†

    211,260       119,990  
  5,000    

United Therapeutics Corp.†

    484,765       390,300  
  47,000    

UnitedHealth Group Inc.

    8,187,456       11,468,470  
  3,400    

USANA Health Sciences Inc.†

    261,289       270,062  
  11,996    

Valeritas Holdings Inc.†

    56,778       31,430  
  4,000    

Waters Corp.†

    285,470       860,960  
  22,000    

Zafgen Inc.†

    59,317       26,180  
  13,500    

Zimmer Biomet Holdings Inc.

    1,363,034       1,589,490  
  32,000    

Zoetis Inc.

    1,044,327       3,631,680  

Shares

       

Cost

   

Market Value

 
  8,688    

Zomedica Pharmaceuticals Corp.†

  $ 2,563     $ 1,999  
  21,297    

Zosano Pharma Corp.†

    87,283       69,641  
   

 

 

   

 

 

 
      67,538,706       99,409,204  
   

 

 

   

 

 

 
  Entertainment — 5.0%

 

 
  26,358    

Charter Communications Inc., Cl. A†

    6,516,053       10,416,154  
  41,600    

Discovery Inc., Cl. A†

    1,391,742       1,277,120  
  309,800    

Discovery Inc., Cl. C†

    5,276,607       8,813,810  
  418,000    

Dover Motorsports Inc.

    856,900       869,440  
  50,000    

Entertainment One Ltd.

    140,629       252,086  
  90,000    

Genting Singapore Ltd.

    74,910       61,197  
  586,000    

Grupo Televisa SAB, ADR

    8,985,991       4,945,840  
  21,500    

Liberty Media Corp.-Liberty Braves, Cl. A†

    479,343       597,700  
  95,758    

Liberty Media Corp.-Liberty Braves, Cl. C†

    1,739,854       2,678,351  
  46,545    

Lions Gate Entertainment Corp., Cl. B

    1,214,824       540,387  
  10,000    

Live Nation Entertainment Inc.†

    274,451       662,500  
  10,000    

Reading International Inc., Cl. A†

    155,401       129,800  
  8,000    

Take-Two Interactive Software Inc.†

    809,673       908,240  
  103,867    

The Madison Square Garden Co., Cl. A†

    9,225,782       29,076,528  
  103,000    

The Walt Disney Co.

    7,013,875       14,382,920  
  40,000    

Tokyo Broadcasting System Holdings Inc.

    796,181       682,651  
  65,000    

Universal Entertainment Corp.

    931,984       1,938,274  
  313,615    

Viacom Inc., Cl. A

    14,075,873       10,694,271  
  5,000    

Viacom Inc., Cl. B

    148,000       149,350  
  240,000    

Vivendi SA

    5,803,696       6,607,007  
   

 

 

   

 

 

 
          65,911,769           95,683,626  
   

 

 

   

 

 

 
  Consumer Services — 4.6%

 

 
  20,000    

eBay Inc.

    416,823       790,000  
  78,935    

GCI Liberty Inc., Cl. A†

    2,586,348       4,851,345  
  225,000    

Groupon Inc.†

    730,145       805,500  
  39,000    

IAC/InterActiveCorp.†

    2,406,941       8,483,670  
  18,642    

Liberty Expedia Holdings Inc., Cl. A†

    411,913       890,901  
  21,000    

Liberty TripAdvisor Holdings Inc., Cl. A†

    247,059       260,400  
  2,000    

Marriott Vacations Worldwide Corp.

    166,389       192,800  
  18,000    

Matthews International Corp., Cl. A

    732,866       627,300  
  241,265    

Qurate Retail Inc.†

    4,025,869       2,989,273  
 

 

See accompanying notes to financial statements.

 

8


The Gabelli Equity Trust Inc.

Schedule of Investments (Continued) — June 30, 2019 (Unaudited)

 

 

Shares

       

Cost

   

Market

Value

 
  COMMON STOCKS (Continued)

 

 
  Consumer Services (Continued)

 

 
  1,885,000    

Rollins Inc.

  $ 43,875,528     $ 67,614,950  
   

 

 

   

 

 

 
      55,599,881       87,506,139  
   

 

 

   

 

 

 
  Business Services — 4.6%

 

 
  14,334    

Allegion plc

    232,677       1,584,624  
  180,035    

Clear Channel Outdoor Holdings Inc.†

    995,816       849,765  
  228,000    

Diebold Nixdorf Inc.†

    2,172,976       2,088,480  
  3,000    

Edenred

    38,786       153,031  
  27,000    

Emerald Expositions Events Inc.

    457,360       301,050  
  40,000    

First Data Corp., Cl. A†

    625,596       1,082,800  
  160,000    

G4S plc

    0       422,641  
  16,000    

Jardine Matheson Holdings Ltd.

    534,478       1,008,320  
  100,000    

Macquarie Infrastructure Corp.

    4,348,720       4,054,000  
  244,500    

Mastercard Inc., Cl. A

    24,943,324           64,677,585  
  110,334    

Resideo Technologies Inc.†

    2,081,990       2,418,521  
  3,000    

Stericycle Inc.†

    174,010       143,250  
  260,000    

The Interpublic Group of Companies Inc.

    4,239,486       5,873,400  
  10,000    

Vectrus Inc.†

    106,200       405,600  
  12,800    

Visa Inc., Cl. A

    140,800       2,221,440  
   

 

 

   

 

 

 
          41,092,219       87,284,507  
   

 

 

   

 

 

 
  Consumer Products — 3.8%

 

 
  100,000    

Avon Products Inc.†

    213,867       388,000  
  14,100    

Christian Dior SE

    534,292       7,391,265  
  27,000    

Church & Dwight Co. Inc.

    383,636       1,972,620  
  205,000    

Edgewell Personal Care Co.†

    14,954,445       5,524,750  
  167,000    

Energizer Holdings Inc.

    6,815,946       6,452,880  
  27,600    

Essity AB, Cl. B

    294,742       848,257  
  2,100    

Givaudan SA

    725,396       5,928,703  
  85,000    

Hanesbrands Inc.

    747,430       1,463,700  
  23,800    

Harley-Davidson Inc.

    1,105,662       852,754  
  1,270    

Hermes International

    444,999       915,859  
  20,000    

Mattel Inc.†

    291,642       224,200  
  10,500    

National Presto Industries Inc.

    515,853       979,545  
  65,000    

Newell Brands Inc.

    1,004,056       1,002,300  
  6,000    

Nilfisk Holding A/S†

    272,517       167,638  
  10,000    

Oil-Dri Corp. of America

    171,255       340,400  
  46,800    

Reckitt Benckiser Group plc

    1,391,995       3,693,220  
  27,600    

Svenska Cellulosa AB,
Cl. B

    73,685       239,854  
  814,900    

Swedish Match AB

    10,248,449       34,399,703  
  9,500    

Weight Watchers International Inc.†

    206,535       181,450  
   

 

 

   

 

 

 
      40,396,402       72,967,098  
   

 

 

   

 

 

 

Shares

       

Cost

   

Market

Value

 
  Energy and Utilities — 3.6%

 

 
  11,000    

ABB Ltd., ADR

  $ 171,270     $ 220,330  
  27,000    

Anadarko Petroleum Corp.

    1,745,346       1,905,120  
  50,000    

Apache Corp.

    1,906,917       1,448,500  
  80,000    

Baker Hughes, a GE Company

    3,044,117       1,970,400  
  80,000    

BP plc, ADR

    3,952,168       3,336,000  
  16,000    

CMS Energy Corp.

    102,219       926,560  
  172,000    

ConocoPhillips

    8,504,848       10,492,000  
  200,000    

El Paso Electric Co.

    5,622,369       13,080,000  
  98,400    

Enbridge Inc.

    2,488,608       3,550,272  
  55,000    

Energy Transfer LP

    830,678       774,400  
  79,062    

Ensco Rowan plc, Cl. A

    3,925,060       674,399  
  20,000    

Evergy Inc.

    1,123,692       1,203,000  
  24,000    

Eversource Energy

    545,324       1,818,240  
  51,600    

Exxon Mobil Corp.

    2,263,473       3,954,108  
  251,700    

Halliburton Co.

    5,809,045       5,723,658  
  60,615    

KLX Energy Services Holdings Inc.†

    1,535,752       1,238,364  
  4,000    

Marathon Oil Corp.

    111,366       56,840  
  22,000    

Marathon Petroleum Corp.

    836,230       1,229,360  
  20,000    

Murphy USA Inc.†

    886,754       1,680,600  
  43,000    

National Fuel Gas Co.

    2,630,792       2,268,250  
  12,000    

NextEra Energy Inc.

    691,134       2,458,320  
  8,000    

NextEra Energy Partners LP

    355,514       386,000  
  1,000    

Niko Resources Ltd., OTC†

    54,403       3  
  3,000    

Niko Resources Ltd., Toronto†(b)

    923       34  
  32,400    

Oceaneering International Inc.†

    437,629       660,636  
  107,500    

Patterson-UTI Energy Inc.

    1,746,607       1,237,325  
  42,100    

Phillips 66

    3,523,890       3,938,034  
  32,680    

RPC Inc.

    439,024       235,623  
  15,000    

Southwest Gas Holdings Inc

    347,695       1,344,300  
  111,500    

The AES Corp.

    981,563       1,868,740  
  712,300    

Weatherford International plc†

    961,260       35,615  
   

 

 

   

 

 

 
          57,575,670           69,715,031  
   

 

 

   

 

 

 
  Cable and Satellite — 3.6%

 

 
  245,600    

AMC Networks Inc.,
Cl. A†

    11,872,791       13,382,744  
  200    

Cable One Inc.

    77,334       234,198  
  193,000    

Comcast Corp., Cl. A

    4,766,154       8,160,040  
  100,400    

DISH Network Corp.,
Cl. A†

    3,492,497       3,856,364  
  48,933    

EchoStar Corp., Cl. A†

    1,933,263       2,168,711  
  145,605    

Liberty Global plc, Cl. A†

    2,504,125       3,929,879  
  326,064    

Liberty Global plc, Cl. C†

    7,734,697       8,650,478  
  21,712    

Liberty Latin America Ltd., Cl. A†

    407,240       374,098  
  42,918    

Liberty Latin America Ltd., Cl. C†

    1,218,719       737,760  
  3,000    

Naspers Ltd., Cl. N

    733,266       728,332  
 

 

See accompanying notes to financial statements.

 

9


The Gabelli Equity Trust Inc.

Schedule of Investments (Continued) — June 30, 2019 (Unaudited)

 

 

Shares

       

Cost

   

Market

Value

 
  COMMON STOCKS (Continued)

 

 
  Cable and Satellite (Continued)

 

 
  447,200    

Rogers Communications Inc., Cl. B

  $ 10,459,495     $ 23,934,144  
  160,000    

Shaw Communications Inc., Cl. B

    407,615       3,260,800  
   

 

 

   

 

 

 
      45,607,196       69,417,548  
   

 

 

   

 

 

 
  Automotive: Parts and Accessories — 3.5%

 

  8,000    

Adient plc

    358,878       194,160  
  9,500    

Aptiv plc

    537,675       767,885  
  93,600    

BorgWarner Inc.

    4,156,216       3,929,328  
  240,900    

Dana Inc.

    2,646,092       4,803,546  
  24,200    

Garrett Motion Inc.†

    254,809       371,470  
  248,200    

Genuine Parts Co.

    16,061,551       25,708,556  
  180,000    

Modine Manufacturing Co.†

    3,181,636       2,575,800  
  60,000    

O’Reilly Automotive Inc.†

    14,516,886       22,159,200  
  105,000    

Standard Motor Products Inc.

    1,181,521       4,760,700  
  68,000    

Superior Industries International Inc.

    1,189,648       235,280  
  12,000    

Visteon Corp.†

    652,054       702,960  
   

 

 

   

 

 

 
          44,736,966           66,208,885  
   

 

 

   

 

 

 
  Broadcasting — 3.0%

 

 
  251,000    

CBS Corp., Cl. A, Voting

    7,713,511       12,560,040  
  20,000    

CBS Corp., Cl. B, Non-Voting

    1,082,346       998,000  
  2,000    

Cogeco Inc.

    39,014       127,616  
  24,000    

Corus Entertainment Inc., OTC, Cl. B

    42,622       112,644  
  500,000    

Entercom Communications Corp., Cl. A

    4,515,626       2,900,000  
  161,733    

Fox Corp., Cl. A

    6,720,006       5,925,897  
  134,999    

Fox Corp., Cl. B

    5,588,959       4,931,513  
  16,000    

Gray Television Inc.†

    14,422       262,240  
  19,250    

Liberty Broadband Corp.,
Cl. A†

    608,060       1,979,670  
  62,192    

Liberty Broadband Corp.,
Cl. C†

    2,218,961       6,481,650  
  88,050    

Liberty Media Corp.-Liberty Formula One, Cl. A†

    2,642,252       3,157,473  
  52,250    

Liberty Media Corp.-Liberty Formula One, Cl. C†

    1,197,836       1,954,673  
  75,000    

Liberty Media Corp.-Liberty SiriusXM, Cl. A†

    1,647,568       2,835,750  
  158,000    

Liberty Media Corp.-Liberty SiriusXM, Cl. C†

    4,150,046       6,000,840  
  282,600    

MSG Networks Inc., Cl. A†

    2,734,673       5,861,124  
  15,000    

Nexstar Media Group Inc.,
Cl. A

    920,250       1,515,000  
  4,500    

Sinclair Broadcast Group Inc., Cl. A

    135,392       241,335  
  85,200    

Television Broadcasts Ltd.

    339,712       142,442  

Shares

       

Cost

   

Market

Value

 
  3,000    

Tribune Media Co.,
Cl. A

  $ 111,614     $ 138,660  
   

 

 

   

 

 

 
      42,422,870       58,126,567  
   

 

 

   

 

 

 
  Aerospace and Defense — 2.8%

 

 
  275,000    

Aerojet Rocketdyne Holdings Inc.†

    4,615,399       12,311,750  
  1,246,553    

BBA Aviation plc

    2,811,697       4,467,410  
  35,800    

Kaman Corp.

    881,634       2,280,102  
  15,001    

L3Harris Technologies Inc.

    1,205,449       2,837,139  
  17,500    

Northrop Grumman Corp.

    2,151,104       5,654,425  
  1,209,000    

Rolls-Royce Holdings plc

    9,301,551       12,903,288  
  85,839,000    

Rolls-Royce Holdings plc, Cl. C†

    110,759       109,012  
  34,000    

The Boeing Co.

    6,473,681       12,376,340  
  1,745    

United Technologies Corp.

    215,804       227,199  
   

 

 

   

 

 

 
          27,767,078           53,166,665  
   

 

 

   

 

 

 
  Machinery — 2.7%

 

 
  25,000    

Astec Industries Inc.

    856,158       814,000  
  12,800    

Caterpillar Inc.

    86,323       1,744,512  
  255,010    

CNH Industrial NV

    2,881,999       2,621,503  
  175,000    

Deere & Co.(a)

    10,024,248       28,999,250  
  220,000    

Xylem Inc.

    10,582,503       18,400,800  
   

 

 

   

 

 

 
      24,431,231       52,580,065  
   

 

 

   

 

 

 
  Telecommunications — 2.6%

 

 
  108,452    

AT&T Inc.

    3,580,633       3,634,227  
  55,400    

BCE Inc.

    1,851,178       2,519,592  
  914,200    

BT Group plc, Cl. A

    3,780,313       2,280,885  
  7,040,836    

Cable & Wireless Jamaica Ltd.†(b)

    128,658       78,209  
  50,000    

CenturyLink Inc.

    610,365       588,000  
  73,000    

Cincinnati Bell Inc.†

    1,294,345       361,350  
  100,000    

Deutsche Telekom AG, ADR

    1,656,300       1,734,000  
  304,282    

Gogo Inc.†

    1,165,945       1,211,042  
  36,000    

Hellenic Telecommunications Organization SA

    452,922       532,163  
  15,000    

Hellenic Telecommunications Organization SA, ADR

    91,062       108,150  
  25,000    

Intelsat SA†

    540,409       486,250  
  264,732    

Koninklijke KPN NV

    448,166       812,772  
  45,000    

Loral Space & Communications Inc.†

    1,762,430       1,552,950  
  16,000    

Oi SA, ADR

    6,333       6,304  
  4,267    

Oi SA, Cl. C, ADR

    118,940       8,577  
  40,053    

Sprint Corp.†

    224,220       263,148  
  21,000    

Telecom Argentina SA, ADR

    127,554       371,070  
  535,000    

Telecom Italia SpA†

    2,073,015       292,129  
  70,000    

Telefonica Brasil SA, ADR

    726,827       911,400  
  560,739    

Telefonica SA, ADR

    8,069,428       4,648,526  
  553,700    

Telephone & Data Systems Inc.

    23,200,835       16,832,480  
  105,000    

Telesites SAB de CV†

    79,714       64,880  
 

 

See accompanying notes to financial statements.

 

10


The Gabelli Equity Trust Inc.

Schedule of Investments (Continued) — June 30, 2019 (Unaudited)

 

 

Shares

       

Cost

   

Market

Value

 
  COMMON STOCKS (Continued)

 

 
  Telecommunications (Continued)

 

 
  25,000    

TELUS Corp.

  $ 233,734     $ 924,172  
  119,000    

Verizon Communications Inc.

    4,950,353       6,798,470  
  70,000    

Vodafone Group plc, ADR

    2,376,792       1,143,100  
  30,000    

Zayo Group Holdings Inc.†

    868,753       987,300  
   

 

 

   

 

 

 
      60,419,224       49,151,146  
   

 

 

   

 

 

 
  Electronics — 2.5%

 

 
  20,000    

Bel Fuse Inc., Cl. A

    540,376       294,000  
  4,000    

Hitachi Ltd., ADR

    287,076       294,320  
  50,000    

Intel Corp.

    1,074,470       2,393,500  
  272,528    

Johnson Controls International plc

        10,763,287           11,258,132  
  34,170    

Koninklijke Philips NV

    180,354       1,489,129  
  2,400    

Mettler-Toledo International Inc.†

    337,270       2,016,000  
  40,000    

TE Connectivity Ltd.

    1,553,958       3,831,200  
  227,000    

Texas Instruments Inc.

    12,116,934       26,050,520  
   

 

 

   

 

 

 
      26,853,725       47,626,801  
   

 

 

   

 

 

 
  Retail — 2.3%

 

 
  80,300    

AutoNation Inc.†

    2,916,937       3,367,782  
  5,000    

Casey’s General Stores Inc.

    531,212       779,950  
  41,000    

Costco Wholesale Corp.

    3,770,311       10,834,660  
  85,000    

CVS Health Corp.

    7,115,483       4,631,650  
  30,000    

GNC Holdings Inc., Cl. A†

    92,299       45,000  
  210,000    

Hertz Global Holdings Inc.†

    2,738,792       3,351,600  
  60,000    

J.C. Penney Co. Inc.†

    412,571       68,400  
  34,000    

Lowe’s Companies Inc.

    3,007,751       3,430,940  
  295,000    

Macy’s Inc.

    5,683,423       6,330,700  
  7,000    

Penske Automotive Group Inc.

    312,532       331,100  
  43,000    

PetIQ Inc.†

    1,201,100       1,417,280  
  16,800    

PetMed Express Inc.

    430,696       263,256  
  30,600    

Sally Beauty Holdings Inc.†

    242,911       408,204  
  16,000    

The Cheesecake Factory Inc.

    523,436       699,520  
  2,500    

Tiffany & Co.

    142,575       234,100  
  10,000    

Vitamin Shoppe, Inc.†

    37,250       39,400  
  64,000    

Walgreens Boots Alliance Inc.

    2,367,140       3,498,880  
  32,000    

Walmart Inc.

    1,618,504       3,535,680  
   

 

 

   

 

 

 
      33,144,923       43,268,102  
   

 

 

   

 

 

 
  Specialty Chemicals — 2.0%

 

 
  11,000    

AdvanSix Inc.†

    134,544       268,730  
  12,000    

Air Products & Chemicals Inc.

    2,000,681       2,716,440  
  11,000    

Ashland Global Holdings Inc

    541,523       879,670  
  22,000    

Axalta Coating Systems Ltd.†

    688,995       654,940  
  28,333    

Dow Inc.

    1,853,905       1,397,100  
  38,333    

DuPont de Nemours Inc.

    3,183,139       2,877,658  
  390,000    

Ferro Corp.†

    4,400,557       6,162,000  
  10,000    

FMC Corp.

    262,417       829,500  

Shares

       

Cost

   

Market

Value

 
  61,500    

GCP Applied Technologies Inc.†

  $ 1,574,558     $ 1,392,360  
  24,000    

H.B. Fuller Co.

    833,663       1,113,600  
  53,000    

International Flavors & Fragrances Inc.

    3,864,047       7,689,770  
  250,000    

OMNOVA Solutions Inc.†

    1,510,742       1,557,500  
  144,800    

Sensient Technologies Corp.

    6,375,318       10,639,904  
  17,000    

SGL Carbon SE†

    214,416       138,215  
  2,000    

The Chemours Co.

    22,594       48,000  
  20,000    

Valvoline Inc.

    393,398       390,600  
   

 

 

   

 

 

 
      27,854,497       38,755,987  
   

 

 

   

 

 

 
  Environmental Services — 2.0%

 

 
  2,296    

Evoqua Water Technologies Corp.†

    29,267       32,695  
  35,000    

Pentair plc

    815,625       1,302,000  
  237,100    

Republic Services Inc.

    12,196,681       20,542,344  
  145,600    

Waste Management Inc.

    8,875,529       16,797,872  
   

 

 

   

 

 

 
          21,917,102           38,674,911  
   

 

 

   

 

 

 
  Hotels and Gaming — 1.9%

 

 
  16,000    

Accor SA

    549,282       686,809  
  41,557    

GVC Holdings plc

    538,448       343,991  
  8,000    

Hyatt Hotels Corp., Cl. A

    263,258       609,040  
  34,000    

Las Vegas Sands Corp.

    632,350       2,009,060  
  4,458,500    

Mandarin Oriental International Ltd.

    7,820,217       7,936,130  
  15,000    

Marriott International, Inc., Cl. A

    1,229,670       2,104,350  
  70,000    

MGM China Holdings Ltd.

    137,917       119,001  
  236,000    

MGM Resorts International

    6,798,162       6,742,520  
  7,560    

Penn National Gaming Inc.†

    216,367       145,606  
  168,800    

Ryman Hospitality Properties Inc., REIT

    5,450,970       13,687,992  
  200,000    

The Hongkong & Shanghai Hotels Ltd.

    155,450       260,635  
  200,000    

William Hill plc

    370,414       392,543  
  4,000    

Wyndham Destinations Inc.

    130,024       175,600  
  4,000    

Wyndham Hotels & Resorts Inc.

    152,872       222,960  
  6,000    

Wynn Resorts Ltd.

    469,634       743,940  
   

 

 

   

 

 

 
      24,915,035       36,180,177  
   

 

 

   

 

 

 
  Aviation: Parts and Services — 1.5%

 

 
  30,000    

Arconic Inc.

    558,049       774,600  
  223,300    

Curtiss-Wright Corp.

    15,432,061       28,388,129  
   

 

 

   

 

 

 
      15,990,110       29,162,729  
   

 

 

   

 

 

 
  Building and Construction — 1.0%

 

 
  28,333    

Arcosa Inc.

    485,186       1,066,171  
  78,210    

Armstrong Flooring Inc.†

    1,150,959       770,369  
  18,000    

Assa Abloy AB, Cl. B

    310,378       406,864  
 

 

See accompanying notes to financial statements.

 

11


The Gabelli Equity Trust Inc.

Schedule of Investments (Continued) — June 30, 2019 (Unaudited)

 

 

Shares

       

Cost

   

Market

Value

 
  COMMON STOCKS (Continued)

 

 
  Building and Construction (Continued)

 

 
  80,000    

Fortune Brands Home & Security Inc.

  $ 2,239,525     $ 4,570,400  
  210,235    

Herc Holdings Inc.†

    7,352,784       9,635,070  
  17,500    

Lennar Corp., Cl. A

    919,328       848,050  
  40,000    

PGT Innovations Inc.†

    572,348       668,800  
  12,000    

Sika AG

    1,556,815       2,047,941  
   

 

 

   

 

 

 
      14,587,323       20,013,665  
   

 

 

   

 

 

 
  Wireless Communications — 0.9%

 

 
  105,000    

America Movil SAB de CV, Cl. L, ADR

    735,232       1,528,800  
  99,000    

Millicom International Cellular SA, SDR

    6,382,128       5,570,392  
  150,000    

NTT DoCoMo Inc.

    2,980,751       3,495,571  
  46,075    

Tim Participacoes SA, ADR

    352,294       689,743  
  25,000    

T-Mobile US Inc.†

    1,098,124       1,853,500  
  104,600    

United States Cellular Corp.†

    4,965,942       4,672,482  
   

 

 

   

 

 

 
          16,514,471           17,810,488  
   

 

 

   

 

 

 
  Computer Software and Services — 0.8%

 

  3,000    

Alphabet Inc., Cl. C†

    3,153,221       3,242,730  
  13,000    

Blucora Inc.†

    65,392       394,810  
  5,500    

Check Point Software Technologies Ltd.†

    93,406       635,855  
  3,000    

Facebook Inc., Cl. A†

    466,804       579,000  
  240,000    

Hewlett Packard Enterprise Co.

    3,476,618       3,588,000  
  515,874    

Internap Corp.†

    2,963,476       1,552,781  
  22,000    

InterXion Holding NV†

    324,408       1,673,980  
  2,000    

Liq Participacoes SA†

    1,103       250  
  20,900    

Rockwell Automation Inc.

    648,748       3,424,047  
   

 

 

   

 

 

 
      11,193,176       15,091,453  
   

 

 

   

 

 

 
  Automotive — 0.8%

 

 
  80,000    

General Motors Co.

    3,044,272       3,082,400  
  180,000    

Navistar International Corp.†

    4,569,128       6,201,000  
  70,000    

PACCAR Inc.

    1,294,774       5,016,200  
   

 

 

   

 

 

 
      8,908,174       14,299,600  
   

 

 

   

 

 

 
  Metals and Mining — 0.6%

 

 
  37,400    

Agnico Eagle Mines Ltd.

    1,530,570       1,916,376  
  50,000    

Barrick Gold Corp.

    1,464,000       788,500  
  30,000    

Cleveland-Cliffs Inc.

    296,432       320,100  
  80,000    

Freeport-McMoRan Inc.

    1,408,020       928,800  
  9,353    

Livent Corp.†

    40,502       64,723  
  4,300    

Materion Corp.

    97,512       291,583  
  50,000    

New Hope Corp. Ltd.

    67,580       95,128  
  143,600    

Newmont Goldcorp Corp.

    5,120,536       5,524,292  
  200,000    

TimkenSteel Corp.†

    3,117,146       1,626,000  
  140,000    

Turquoise Hill Resources Ltd.†

    726,343       173,600  

Shares

       

Cost

   

Market

Value

 
  15,000    

Vale SA, ADR

  $ 171,892     $ 201,600  
   

 

 

   

 

 

 
      14,040,533       11,930,702  
   

 

 

   

 

 

 
  Transportation — 0.5%

 

 
  131,200    

GATX Corp.

    4,730,843       10,402,848  
   

 

 

   

 

 

 
  Communications Equipment — 0.5%

 

 
  4,000    

Apple Inc.

    687,701       791,680  
  275,000    

Corning Inc.

    7,244,501       9,138,250  
   

 

 

   

 

 

 
      7,932,202       9,929,930  
   

 

 

   

 

 

 
  Publishing — 0.5%

 

 
  1,100    

Graham Holdings Co., Cl. B

    588,093       759,033  
  87,700    

Meredith Corp.

    4,424,244       4,828,762  
  125,000    

News Corp., Cl. A

    1,939,129       1,686,250  
  100,600    

News Corp., Cl. B

    1,289,652       1,404,376  
  70,000    

The E.W. Scripps Co., Cl. A

    831,325       1,070,300  
   

 

 

   

 

 

 
      9,072,443       9,748,721  
   

 

 

   

 

 

 
  Real Estate — 0.5%

 

 
  15,000    

Gaming and Leisure Properties Inc., REIT

    183,300       584,700  
  56,000    

Griffin Industrial Realty Inc.

    542,694       1,979,600  
  29,000    

Rayonier Inc., REIT

    454,837       878,700  
  325,000    

The St. Joe Co.†

    5,900,736       5,616,000  
  15,000    

Weyerhaeuser Co., REIT

    442,013       395,100  
   

 

 

   

 

 

 
      7,523,580       9,454,100  
   

 

 

   

 

 

 
  Agriculture — 0.5%

 

 
  200,000    

Archer-Daniels-Midland Co.

    9,150,371       8,160,000  
  15,000    

Corteva Inc.†

    505,749       443,550  
  10,000    

The Mosaic Co.

    428,085       250,300  
   

 

 

   

 

 

 
      10,084,205       8,853,850  
   

 

 

   

 

 

 
  Manufactured Housing and Recreational Vehicles — 0.2%

 

  5,000    

Martin Marietta Materials Inc.

    106,125       1,150,550  
  30,000    

Nobility Homes Inc.

    349,956       675,000  
  42,000    

Skyline Champion Corp.†

    256,482       1,149,960  
   

 

 

   

 

 

 
      712,563       2,975,510  
   

 

 

   

 

 

 
 

TOTAL COMMON STOCKS

      1,186,688,911         1,890,881,298  
   

 

 

   

 

 

 
  CLOSED-END FUNDS — 0.7%

 

 
  122,000    

Altaba Inc.†

    4,042,811       8,463,140  
  4,285    

Royce Global Value Trust Inc.

    37,280       45,207  
  45,000    

Royce Value Trust Inc.

    598,747       626,400  
  92,106    

The Central Europe, Russia, and Turkey Fund Inc.

    2,648,248       2,505,283  
  154,038    

The New Germany Fund Inc.

    2,077,654       2,184,259  
   

 

 

   

 

 

 
      9,404,740       13,824,289  
   

 

 

   

 

 

 
 

TOTAL CLOSED-END FUNDS

    9,404,740       13,824,289  
   

 

 

   

 

 

 
 

 

See accompanying notes to financial statements.

 

12


The Gabelli Equity Trust Inc.

Schedule of Investments (Continued) — June 30, 2019 (Unaudited)

 

 

Shares

       

Cost

   

Market

Value

 
  CONVERTIBLE PREFERRED STOCKS — 0.0%

 

  Telecommunications — 0.0%

 

 
  21,000    

Cincinnati Bell Inc., 6.750%, Ser. B

  $         462,045     $         778,155  
   

 

 

   

 

 

 
  RIGHTS — 0.0%

 

 
  Entertainment — 0.0%

 

 
  139,123    

Media General Inc., CVR†(b)

    0       0  
   

 

 

   

 

 

 
  Retail — 0.0%

 

 
  210,000    

Hertz Global Holdings Inc., expire 07/12/19†

    0       409,500  
   

 

 

   

 

 

 
 

TOTAL RIGHTS

    0       409,500  
   

 

 

   

 

 

 

Principal

Amount

                 
  U.S. GOVERNMENT OBLIGATIONS — 0.7%

 

  $12,970,000    

U.S. Treasury Bills, 1.972% to 2.182%††, 07/23/19 to 09/19/19

    12,913,132       12,913,809  
   

 

 

   

 

 

 
 

TOTAL INVESTMENTS — 100.0%

  $ 1,209,468,828       1,918,807,051  
   

 

 

   
    

Market

Value

 

Other Assets and Liabilities (Net)

   $ 1,062,796  

PREFERRED STOCK
(12,520,529 preferred shares outstanding)

     (412,913,225
  

 

 

 

NET ASSETS — COMMON STOCK
(255,195,756 common shares outstanding)

   $ 1,506,956,622  
  

 

 

 

NET ASSET VALUE PER COMMON SHARE ($1,506,956,622 ÷ 255,195,756 shares outstanding)

   $ 5.91  
  

 

 

 

                                         

(a)

Securities, or a portion thereof, with a value of $47,887,400 were pledged as collateral for futures contracts.

(b)

Security is valued using significant unobservable inputs and is classified as Level 3 in the fair value hierarchy.

Non-income producing security.

††

Represents annualized yields at dates of purchase.

ADR

American Depositary Receipt

CVR

Contingent Value Right

REIT

Real Estate Investment Trust

SDR

Swedish Depositary Receipt

 

Geographic Diversification

  

% of Total
Investments

 

Market

Value

North America

       83.7 %     $ 1,606,376,560

Europe

       12.9       247,538,900

Japan

       1.7       32,749,303

Latin America

       1.1       21,490,674

Asia/Pacific

       0.5       9,923,282

South Africa

       0.1       728,332
    

 

 

     

 

 

 

Total Investments

       100.0 %     $ 1,918,807,051
    

 

 

     

 

 

 
 

 

As of June 30, 2019, futures contracts outstanding were as follows:

 

Description    Long/Short      Number of
Contracts
     Expiration
Date
     Notional
Amount
     Value    Unrealized
Depreciation

S&P 500 Futures (E-Mini)

   Short          117          09/20/19        $ 17,223,570        $ (297,473 )      $ (297,473 )
                                   

 

 

 

TOTAL FUTURES

                                    $ (297,473 )
                                   

 

 

 

 

See accompanying notes to financial statements.

 

13


The Gabelli Equity Trust Inc.

 

Statement of Assets and Liabilities

June 30, 2019 (Unaudited)

 

 

Assets:

  

Investments, at value (cost $1,209,468,828)

   $ 1,918,807,051  

Foreign currency, at value (cost $1,900)

     1,901  

Cash

     68,498  

Deposit at brokers

     810,810  

Receivable for investments sold

     51,071  

Dividends receivable

     2,912,975  

Deferred offering expense

     102,019  

Prepaid expenses

     16,170  
  

 

 

 

Total Assets

     1,922,770,495  
  

 

 

 

Liabilities:

  

Distributions payable

     279,343  

Payable for investments purchased

     123,083  

Payable for investment advisory fees

     2,220,528  

Payable for payroll expenses

     58,936  

Payable for accounting fees

     7,500  

Variation margin payable

     77,805  

Other accrued expenses

     133,453  
  

 

 

 

Total Liabilities

     2,900,648  
  

 

 

 

Cumulative Preferred Stock, $0.001 par value:

  

Series C (Auction Rate, $25,000 liquidation value, 5,200 shares authorized with 2,880 shares issued and outstanding)

     72,000,000  

Series D (5.875%, $25 liquidation value, 3,000,000 shares authorized with 2,363,860 shares issued and outstanding)

     59,096,500  

Series E (Auction Rate, $25,000 liquidation value, 2,000 shares authorized with 1,120 shares issued and outstanding)

     28,000,000  

Series G (5.000%, $25 liquidation value, 3,280,477 shares authorized with 2,779,796 shares issued and outstanding)

     69,494,900  

Series H (5.000%, $25 liquidation value, 4,198,880 shares authorized with 4,172,873 shares issued and outstanding)

     104,321,825  

Series J (5.450%, $25 liquidation value, 4,500,000 shares authorized with 3,200,000 shares issued and outstanding)

     80,000,000  
  

 

 

 

Total Preferred Stock

     412,913,225  
  

 

 

 

Net Assets Attributable to Common Shareholders

   $ 1,506,956,622  
  

 

 

 

Net Assets Attributable to Common Shareholders Consist of:

  

Paid-in capital

   $ 824,482,341  

Total distributable earnings

     682,474,281  
  

 

 

 

Net Assets

   $ 1,506,956,622  
  

 

 

 

Net Asset Value per Common Share:

  

($1,506,956,622 ÷ 255,195,756 shares outstanding at $0.001 par value; 337,024,900 shares authorized)

   $ 5.91  
  

 

 

 

Statement of Operations

For the Six Months Ended June 30, 2019 (Unaudited)

 

 

Investment Income:

  

Dividends (net of foreign withholding taxes of $788,228)

   $ 16,595,037  

Interest

     351,149  
  

 

 

 

Total Investment Income

     16,946,186  
  

 

 

 

Expenses:

  

Investment advisory fees

     9,442,956  

Shareholder communications expenses

     198,325  

Custodian fees

     119,978  

Directors’ fees

     81,288  

Payroll expenses

     70,780  

Shareholder services fees

     68,781  

Legal and audit fees

     45,706  

Accounting fees

     22,500  

Interest expense

     8  

Auction agent fees(a)

     (873,578

Miscellaneous expenses

     207,340  
  

 

 

 

Total Expenses

     9,384,084  
  

 

 

 

Less:

  

Advisory fee reduction on unsupervised assets (See Note 3)

     (2,307

Expenses paid indirectly by broker (See Note 3)

     (7,441

Custodian fee credits

     (3,188
  

 

 

 

Total Reductions and Credits

     (12,936
  

 

 

 

Net Expenses

     9,371,148  
  

 

 

 

Net Investment Income

     7,575,038  
  

 

 

 

Net Realized and Unrealized Gain/(Loss) on Investments, Futures Contracts, and Foreign Currency:

  

Net realized gain on investments

     32,283,605  

Net realized loss on futures contracts

     (1,660,469

Net realized loss on foreign currency transactions

     (5,155
  

 

 

 

Net realized gain on investments, futures contracts, and foreign currency transactions

     30,617,981  
  

 

 

 

Net change in unrealized appreciation/depreciation:

  

on investments

     214,077,261  

on futures contracts

     (297,473

on foreign currency translations

     (1,002
  

 

 

 

Net change in unrealized appreciation/depreciation on investments, futures contracts, and foreign currency translations

     213,778,786  
  

 

 

 

Net Realized and Unrealized Gain/(Loss) on Investments, Futures Contracts, and Foreign Currency

     244,396,767  
  

 

 

 

Net Increase in Net Assets Resulting from Operations

     251,971,805  
  

 

 

 

Total Distributions to Preferred Shareholders

     (10,355,567
  

 

 

 

Net Increase in Net Assets Attributable to Common Shareholders Resulting from Operations

   $ 241,616,238  
  

 

 

 

                                         

(a)

This amount represents the reversal of auction agent fees from earlier fiscal periods, and not for the period covered by this report.

 

 

See accompanying notes to financial statements.

 

14


The Gabelli Equity Trust Inc.

Statement of Changes in Net Assets Attributable to Common Shareholders

 

 

     Six Months Ended
June 30, 2019
(Unaudited)
  Year Ended
December 31, 2018

Operations:

        

Net investment income

     $ 7,575,038     $ 17,063,275

Net realized gain on investments, futures contracts, and foreign currency transactions

       30,617,981       156,079,199

Net change in unrealized appreciation/depreciation on investments, futures contracts, and foreign currency translations

       213,778,786       (301,016,852 )
    

 

 

     

 

 

 

Net Increase/(Decrease) in Net Assets Resulting from Operations

       251,971,805       (127,874,378 )
    

 

 

     

 

 

 

Distributions to Preferred Shareholders

       (10,355,567 )*       (19,766,096 )
    

 

 

     

 

 

 

Net Increase/(Decrease) in Net Assets Attributable to Common Shareholders Resulting from Operations

       241,616,238       (147,640,474 )
    

 

 

     

 

 

 

Distributions to Common Shareholders:

        

Accumulated earnings

       (42,637,967 )*       (152,700,630 )

Return of capital

       (33,501,258 )*       (8,979,028 )
    

 

 

     

 

 

 

Total Distributions to Common Shareholders

       (76,139,225 )       (161,679,658 )
    

 

 

     

 

 

 

Fund Share Transactions:

        

Net increase in net assets from common shares issued upon reinvestment of distributions

       10,873,445       7,658,026

Rights offering costs for common shares charged to paid-in capital

             (58,709 )
    

 

 

     

 

 

 

Net Increase in Net Assets from Fund Share Transactions

       10,873,445       7,599,317
    

 

 

     

 

 

 

Net Increase/(Decrease) in Net Assets Attributable to Common Shareholders

       176,350,458       (301,720,815 )

Net Assets Attributable to Common Shareholders:

        

Beginning of year

       1,330,606,164       1,632,326,979
    

 

 

     

 

 

 

End of period

     $ 1,506,956,622     $ 1,330,606,164
    

 

 

     

 

 

 

                                                                                                                                   

 

*

Based on year to date book income. Amounts are subject to change and recharacterization at year end.

 

See accompanying notes to financial statements.

 

15


The Gabelli Equity Trust Inc.

Financial Highlights

 

 

Selected data for a common share outstanding throughout each period:

 

    Six Months Ended                                
    June 30, 2019     Year Ended December 31,  
    (Unaudited)     2018     2017     2016     2015     2014  

Operating Performance:

           

Net asset value, beginning of year

  $ 5.25     $ 6.47     $ 5.84     $ 5.70     $ 6.78     $ 7.23  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net investment income

    0.03       0.07       0.04       0.07       0.06       0.07  

Net realized and unrealized gain/(loss) on investments, futures contracts, swap contracts, and foreign currency transactions

    0.97       (0.57     1.42       0.75       (0.44     0.30  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total from investment operations

    1.00       (0.50     1.46       0.82       (0.38     0.37  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions to Preferred Shareholders: (a)

           

Net investment income

    (0.01 )*      (0.01     (0.00 )(b)      (0.01     (0.01     (0.01

Net realized gain

    (0.03 )*      (0.07     (0.08     (0.06     (0.05     (0.05
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions to preferred shareholders

    (0.04     (0.08     (0.08     (0.07     (0.06     (0.06
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net Increase/(Decrease) in Net Assets Attributable to Common Shareholders Resulting from Operations

    0.96       (0.58     1.38       0.75       (0.44     0.31  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Distributions to Common Shareholders:

           

Net investment income

    (0.13 )*      (0.06     (0.04     (0.08     (0.05     (0.05

Net realized gain

    (0.04 )*      (0.54     (0.57     (0.52     (0.44     (0.49

Return of capital

    (0.13 )*      (0.04     (0.00 )(b)      (0.00 )(b)      (0.15     (0.10
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total distributions to common shareholders

    (0.30     (0.64     (0.61     (0.60     (0.64     (0.64
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Fund Share Transactions:

           

Increase/decrease in net asset value from common share transactions

    0.00 (b)            (0.14                 (0.12

Increase in net asset value from repurchase of preferred shares

                0.00 (b)      0.00 (b)      0.00 (b)      0.00 (b) 

Offering costs and adjustment to offering costs for preferred shares charged to paid-in capital

                      (0.01            

Offering costs and adjustment to offering costs for common shares charged to paid-in capital

          (0.00 )(b)      (0.00 )(b)                   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Fund share transactions

    0.00 (b)      (0.00 )(b)      (0.14     (0.01     0.00 (b)      (0.12
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net Asset Value Attributable to Common Shareholders, End of Period

  $ 5.91     $ 5.25     $ 6.47     $ 5.84     $ 5.70     $ 6.78  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

NAV total return †

    18.43     (10.17 )%      24.64     13.66     (6.85 )%      4.68
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Market value, end of period

  $ 6.18     $ 5.10     $ 6.19     $ 5.52     $ 5.31     $ 6.47  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Investment total return ††

    27.47     (8.43 )%      24.65     15.71     (8.54 )%      (6.08 )% 
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Ratios to Average Net Assets and Supplemental Data:

           

Net assets including liquidation value of preferred shares, end of period (in 000’s)

  $ 1,919,870     $ 1,743,519     $ 2,045,240     $ 1,693,448     $ 1,582,823     $ 1,820,361  

Net assets attributable to common shares, end of period (in 000’s)

  $ 1,506,957     $ 1,330,606     $ 1,632,327     $ 1,280,115     $ 1,249,157     $ 1,486,491  

Ratio of net investment income to average net assets attributable to common shares before preferred distributions

    1.03     1.07     0.64     1.23     0.91     0.82

Ratio of operating expenses to average net assets attributable to common shares:

           

before fee reductions(c)

    1.27 %(d)(e)(f)      1.37 %(e)      1.42 %(e)      1.44 %(e)      1.36 %(e)      1.37

net of fee reductions, if any(g)

    1.27 %(d)(e)(f)      1.27 %(e)      1.42 %(e)      1.44 %(e)      1.25 %(e)      1.33

Portfolio turnover rate

    3.1     17.1     11.4     12.7     8.9     10.9

Cumulative Preferred Stock:

           

Auction Rate Series C Preferred

           

Liquidation value, end of period (in 000’s)

  $ 72,000     $ 72,000     $ 72,000     $ 72,000     $ 72,000     $ 72,000  

Total shares outstanding (in 000’s)

    3       3       3       3       3       3  

Liquidation preference per share

  $ 25,000     $ 25,000     $ 25,000     $ 25,000     $ 25,000     $ 25,000  

Liquidation value(h)

  $ 25,000     $ 25,000     $ 25,000     $ 25,000     $ 25,000     $ 25,000  

Asset coverage per share(i)

  $ 116,239     $ 105,562     $ 123,830     $ 102,426     $ 118,593     $ 136,308  

 

See accompanying notes to financial statements.

 

16


The Gabelli Equity Trust Inc.

Financial Highlights (Continued)

 

 

    Six Months Ended                                
    June 30, 2019     Year Ended December 31,  
    (Unaudited)     2018     2017     2016     2015     2014  

Cumulative Preferred Stock (continued):

           

5.875% Series D Preferred

           

Liquidation value, end of period (in 000’s)

    $  59,097     $ 59,097     $ 59,097     $ 59,097     $ 59,097     $ 59,097  

Total shares outstanding (in 000’s)

    2,364       2,364       2,364       2,364       2,364       2,364  

Liquidation preference per share

    $    25.00     $ 25.00     $ 25.00     $ 25.00     $ 25.00     $ 25.00  

Average market value(j)

    $    25.90     $ 25.62     $ 26.16     $ 26.22     $ 25.69     $ 25.21  

Asset coverage per share(i)

    $  116.24     $ 105.56     $ 123.83     $ 102.43     $ 118.59     $ 136.31  

Auction Rate Series E Preferred

           

Liquidation value, end of period (in 000’s)

    $  28,000     $ 28,000     $ 28,000     $ 28,000     $ 28,000     $ 28,000  

Total shares outstanding (in 000’s)

    1       1       1       1       1       1  

Liquidation preference per share

    $  25,000     $ 25,000     $ 25,000     $ 25,000     $ 25,000     $ 25,000  

Liquidation value(h)

    $  25,000     $ 25,000     $ 25,000     $ 25,000     $ 25,000     $ 25,000  

Asset coverage per share(i)

    $116,239     $ 105,562     $ 123,830     $ 102,426     $ 118,593     $ 136,308  

Series G Preferred

           

Liquidation value, end of period (in 000’s)

    $  69,495     $ 69,495     $ 69,495     $ 69,743     $ 69,925     $ 70,099  

Total shares outstanding (in 000’s)

    2,780       2,780       2,780       2,791       2,797       2,804  

Liquidation preference per share

    $    25.00     $ 25.00     $ 25.00     $ 25.00     $ 25.00     $ 25.00  

Average market value(j)

    $    23.99     $ 23.92     $ 24.50     $ 24.67     $ 23.78     $ 23.32  

Asset coverage per share(i)

    $  116.24     $ 105.56     $ 123.83     $ 102.43     $ 118.59     $ 136.31  

5.000% Series H Preferred

           

Liquidation value, end of period (in 000’s)

    $104,322     $ 104,322     $ 104,322     $ 104,494     $ 104,644     $ 104,674  

Total shares outstanding (in 000’s)

    4,173       4,173       4,173       4,180       4,186       4,187  

Liquidation preference per share

    $    25.00     $ 25.00     $ 25.00     $ 25.00     $ 25.00     $ 25.00  

Average market value(j)

    $    24.13     $ 24.18     $ 24.64     $ 25.00     $ 24.33     $ 22.82  

Asset coverage per share(i)

    $  116.24     $ 105.56     $ 123.83     $ 102.43     $ 118.59     $ 136.31  

5.450% Series J Preferred

           

Liquidation value, end of period (in 000’s)

    $  80,000     $ 80,000     $ 80,000     $ 80,000              

Total shares outstanding (in 000’s)

    3,200       3,200       3,200       3,200              

Liquidation preference per share

    $    25.00     $ 25.00     $ 25.00     $ 25.00              

Average market value(j)

    $    25.74     $ 25.14     $ 25.36     $ 25.43              

Asset coverage per share(i)

    $  116.24     $ 105.56     $ 123.83     $ 102.43              

Asset Coverage(k)

    465     422     495     410     474     545

                                             

Based on net asset value per share, adjusted for reinvestment of distributions at net asset value on the ex-dividend dates and adjustments for the rights offering. Total return for a period of less than one year is not annualized.

††

Based on market value per share, adjusted for reinvestment of distributions at prices determined under the Fund’s dividend reinvestment plan. Total return for a period of less than one year is not annualized.

*

Based on year to date book income. Amounts are subject to change and recharacterization at year end.

(a)

Calculated based on average common shares outstanding on the record dates throughout the years.

(b)

Amount represents less than $0.005 per share.

(c)

Ratio of operating expenses to average net assets including liquidation value of preferred shares before fee reductions for the six months ended June 30, 2019 and the years ended December 31, 2018, 2017, 2016, 2015, and 2014 would have been 0.99%, 1.09%, 1.10%, 1.10%, 1.10%, and 1.10%, respectively.

(d)

Annualized.

(e)

The Fund received credits from a designated broker who agreed to pay certain Fund operating expenses. For the six months ended June 30, 2019 and the years ended December 31, 2018, 2017, 2016, and 2015, there was no impact on the expense ratios.

(f)

Ratio of operating expenses to average net assets includes reversal of auction agent fees from earlier fiscal periods as disclosed on the Statement of Operations. The ratio of operating expenses to average net assets attributable to common shares and the ratio of operating expenses to average net assets including liquidation value of preferred shares, excluding the reversal of auction agent fees, were 1.39% and 1.08%, respectively, for the six months ended June 30, 2019.

(g)

Ratio of operating expenses to average net assets including liquidation value of preferred shares net of fee reductions for the six months ended June 30, 2019 and the years ended December 31, 2018, 2017, 2016, 2015, and 2014 would have been 0.99%, 1.01%, 1.10%, 1.10%, 1.01%, and 1.07%, respectively.

(h)

Since February 2008, the weekly auctions have failed. Holders that have submitted orders have not been able to sell any or all of their shares in the auction.

(i)

Asset coverage per share is calculated by combining all series of preferred stock.

(j)

Based on weekly prices.

(k)

Asset coverage is calculated by combining all series of preferred stock.

 

See accompanying notes to financial statements.

 

17


The Gabelli Equity Trust Inc.

Notes to Financial Statements (Unaudited)

 

1. Organization. The Gabelli Equity Trust Inc. (the Fund) is a non-diversified closed-end management investment company organized as a Maryland corporation on May 20, 1986 and registered under the Investment Company Act of 1940, as amended (the 1940 Act), whose primary objective is long term growth of capital with income as a secondary objective. Investment operations commenced on August 21, 1986.

The Fund will invest at least 80% of its assets in equity securities under normal market conditions (the 80% Policy). The 80% Policy may be changed without shareholder approval. The Fund will provide shareholders with notice at least sixty days prior to the implementation of any changes in the 80% Policy.

2. Significant Accounting Policies. As an investment company, the Fund follows the investment company accounting and reporting guidance, which is part of U.S. generally accepted accounting principles (GAAP) that may require the use of management estimates and assumptions in the preparation of its financial statements. Actual results could differ from those estimates. The following is a summary of significant accounting policies followed by the Fund in the preparation of its financial statements.

New Accounting Pronouncements. To improve the effectiveness of fair value disclosure requirements, the Financial Accounting Standards Board recently issued Accounting Standard Update (ASU) 2018-13, Fair Value Measurement Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement (ASU 2018-13), which adds, removes, and modifies certain aspects relating to fair value disclosure. ASU 2018-13 is effective for interim and annual reporting periods beginning after December 15, 2019; early adoption of the additions relating to ASU 2018-13 is not required, even if early adoption is elected for the removals under ASU 2018-13. Management has early adopted the removals set forth in ASU 2018-13 in these financial statements and has not early adopted the additions set forth in ASU 2018-13.

Security Valuation. Portfolio securities listed or traded on a nationally recognized securities exchange or traded in the U.S. over-the-counter market for which market quotations are readily available are valued at the last quoted sale price or a market’s official closing price as of the close of business on the day the securities are being valued. If there were no sales that day, the security is valued at the average of the closing bid and asked prices or, if there were no asked prices quoted on that day, then the security is valued at the closing bid price on that day. If no bid or asked prices are quoted on such day, the security is valued at the most recently available price or, if the Board of Directors (the Board) so determines, by such other method as the Board shall determine in good faith to reflect its fair market value. Portfolio securities traded on more than one national securities exchange or market are valued according to the broadest and most representative market, as determined by Gabelli Funds, LLC (the Adviser).

Portfolio securities primarily traded on a foreign market are generally valued at the preceding closing values of such securities on the relevant market, but may be fair valued pursuant to procedures established by the Board if market conditions change significantly after the close of the foreign market, but prior to the close of business on the day the securities are being valued. Debt obligations for which market quotations are readily available are valued at the average of the latest bid and asked prices. If there were no asked prices quoted on such day, the security is valued using the closing bid price, unless the Board determines such amount does not reflect the securities’ fair value, in which case these securities will be fair valued as determined by the Board. Certain securities are valued principally using dealer quotations. Futures contracts are valued at the closing settlement price of the exchange or board of trade on which the applicable contract is traded. OTC futures and options on futures for which market quotations are readily available will be valued by quotations

 

18


The Gabelli Equity Trust Inc.

Notes to Financial Statements (Unaudited) (Continued)

 

 

received from a pricing service or, if no quotations are available from a pricing service, by quotations obtained from one or more dealers in the instrument in question by the Adviser.

Securities and assets for which market quotations are not readily available are fair valued as determined by the Board. Fair valuation methodologies and procedures may include, but are not limited to: analysis and review of available financial and non-financial information about the company; comparisons with the valuation and changes in valuation of similar securities, including a comparison of foreign securities with the equivalent U.S. dollar value American Depositary Receipt securities at the close of the U.S. exchange; and evaluation of any other information that could be indicative of the value of the security.

The inputs and valuation techniques used to measure fair value of the Fund’s investments are summarized into three levels as described in the hierarchy below:

 

   

Level 1 — quoted prices in active markets for identical securities;

 

   

Level 2 — other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.); and

 

   

Level 3 — significant unobservable inputs (including the Board’s determinations as to the fair value of investments).

 

19


The Gabelli Equity Trust Inc.

Notes to Financial Statements (Unaudited) (Continued)

 

 

A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input both individually and in the aggregate that is significant to the fair value measurement. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. The summary of the Fund’s investments in securities by inputs used to value the Fund’s investments as of June 30, 2019 is as follows:

 

    Valuation Inputs    
    Level 1
Quoted Prices
  Level 2 Other Significant
Observable Inputs
  Level 3 Significant
Unobservable Inputs
  Total Market Value
at 6/30/19

INVESTMENTS IN SECURITIES:

               

ASSETS (Market Value):

               

Common Stocks:

               

Aerospace and Defense

    $ 53,057,653     $ 109,012           $ 53,166,665

Diversified Industrial

      100,801,760       662,525             101,464,285

Energy and Utilities

      69,714,997           $ 34       69,715,031

Health Care

      99,359,127       50,077           99,409,204

Manufactured Housing and Recreational Vehicles

      2,300,510       675,000             2,975,510

Telecommunications

      49,072,937             78,209       49,151,146

Other Industries (a)

      1,514,999,457                   1,514,999,457

Total Common Stocks

      1,889,306,441       1,496,614       78,243       1,890,881,298

Closed-End Funds

      13,824,289                   13,824,289

Convertible Preferred Stocks (a)

            778,155             778,155

Rights (a)

      409,500             0       409,500

U.S. Government Obligations

            12,913,809             12,913,809

TOTAL INVESTMENTS IN SECURITIES – ASSETS

    $ 1,903,540,230     $ 15,188,578     $ 78,243     $ 1,918,807,051

OTHER FINANCIAL INSTRUMENTS:*

               

LIABILITIES (Net Unrealized Depreciation):

               

EQUITY CONTRACTS

               

Index Futures Contracts - Short Position

    $ (297,473                 $ (297,473

                                             

(a)

Please refer to the Schedule of Investments (SOI) for the industry classifications of these portfolio holdings.

*

Other financial instruments are derivatives reflected in the SOI, such as options, futures, forwards, and swaps, which may be valued at the unrealized appreciation/(depreciation) of the instrument.

During the six months ended June 30, 2019, the Fund did not have material transfers into or out of Level 3.

Additional Information to Evaluate Qualitative Information.

    General. The Fund uses recognized industry pricing services – approved by the Board and unaffiliated with the Adviser – to value most of its securities, and uses broker quotes provided by market makers of securities not valued by these and other recognized pricing sources. Several different pricing feeds are received to value domestic equity securities, international equity securities, preferred equity securities, and fixed income securities. The data within these feeds are ultimately sourced from major stock exchanges and trading systems where these securities trade. The prices supplied by external sources are checked by obtaining quotations or actual transaction prices from market participants. If a price obtained from the pricing source is deemed unreliable, prices will be sought from another pricing service or from a broker/dealer that trades that security or similar securities.

    Fair Valuation. Fair valued securities may be common or preferred equities, warrants, options, rights, or fixed income obligations. Where appropriate, Level 3 securities are those for which market quotations are not

 

20


The Gabelli Equity Trust Inc.

Notes to Financial Statements (Unaudited) (Continued)

 

 

available, such as securities not traded for several days, or for which current bids are not available, or which are restricted as to transfer. When fair valuing a security, factors to consider include recent prices of comparable securities that are publicly traded, reliable prices of securities not publicly traded, the use of valuation models, current analyst reports, valuing the income or cash flow of the issuer, or cost if the preceding factors do not apply. A significant change in the unobservable inputs could result in a lower or higher value in Level 3 securities. The circumstances of Level 3 securities are frequently monitored to determine if fair valuation measures continue to apply.

The Adviser reports quarterly to the Board the results of the application of fair valuation policies and procedures. These may include backtesting the prices realized in subsequent trades of these fair valued securities to fair values previously recognized.

Derivative Financial Instruments. The Fund may engage in various portfolio investment strategies by investing in derivative financial instruments for the purposes of increasing the income of the Fund, hedging against changes in the value of its portfolio securities and in the value of securities it intends to purchase, or hedging against a specific transaction with respect to either the currency in which the transaction is denominated or another currency. Investing in certain derivative financial instruments, including participation in the options, futures, or swap markets, entails certain execution, liquidity, hedging, tax, and securities, interest, credit, or currency market risks. Losses may arise if the Adviser’s prediction of movements in the direction of the securities, foreign currency, and interest rate markets is inaccurate. Losses may also arise if the counterparty does not perform its duties under a contract, or, in the event of default, the Fund may be delayed in or prevented from obtaining payments or other contractual remedies owed to it under derivative contracts. The creditworthiness of the counterparties is closely monitored in order to minimize these risks. Participation in derivative transactions involves investment risks, transaction costs, and potential losses to which the Fund would not be subject absent the use of these strategies. The consequences of these risks, transaction costs, and losses may have a negative impact on the Fund’s ability to pay distributions.

Collateral requirements differ by type of derivative. Collateral requirements are set by the broker or exchange clearing house for exchange traded derivatives, while collateral terms are contract specific for derivatives traded over-the-counter. Securities pledged to cover obligations of the Fund under derivative contracts are noted in the Schedule of Investments. Cash collateral, if any, pledged for the same purpose will be reported separately as Deposit at brokers, in the Statement of Assets and Liabilities.

The Fund’s policy with respect to offsetting is that, absent an event of default by the counterparty or a termination of the agreement, the master agreement does not result in an offset of reported amounts of financial assets and financial liabilities in the Statement of Assets and Liabilities across transactions between the Fund and the applicable counterparty. The enforceability of the right to offset may vary by jurisdiction.

The Fund’s derivative contracts held at June 30, 2019, if any, are not accounted for as hedging instruments under GAAP and are disclosed in the Schedule of Investments together with the related counterparty.

Futures Contracts. The Fund may engage in futures contracts for the purpose of hedging against changes in the value of its portfolio securities and in the value of securities it intends to purchase. Upon entering into a futures contract, the Fund is required to deposit with the broker an amount of cash or cash equivalents equal to a certain percentage of the contract amount. This is known as the “initial margin.” Subsequent payments

 

21


The Gabelli Equity Trust Inc.

Notes to Financial Statements (Unaudited) (Continued)

 

 

(variation margin) are made or received by the Fund each day, depending on the daily fluctuations in the value of the contract, and are included in unrealized appreciation/depreciation on futures contracts. The Fund recognizes a realized gain or loss when the contract is closed.

There are several risks in connection with the use of futures contracts as a hedging instrument. The change in value of futures contracts primarily corresponds with the value of their underlying instruments, which may not correlate with the change in value of the hedged investments. In addition, there is the risk that the Fund may not be able to enter into a closing transaction because of an illiquid secondary market. Open positions in futures contracts at June 30, 2019 are reflected within the Schedule of Investments.

During the six months ended June 30, 2019, the Fund held an average monthly notional amount of equity futures contracts of approximately $16,547,993, while outstanding.

As of June 30, 2019, the equity risk exposure associated with the futures contracts can be found in the Statement of Assets and Liabilities, under Liabilities, Variation margin payable. For the six months ended June 30, 2019, the effect of futures contracts with equity risk exposure can be found in the Statement of Operations, under Net Realized and Unrealized Gain/(Loss) on Investments, Futures Contracts, and Foreign Currency; Net realized loss on futures contracts; and Net change in unrealized appreciation/depreciation on futures contracts.

Limitations on the Purchase and Sale of Futures Contracts, Certain Options, and Swaps. Subject to the guidelines of the Board, the Fund may engage in “commodity interest” transactions (generally, transactions in futures, certain options, certain currency transactions, and certain types of swaps) only for bona fide hedging or other permissible transactions in accordance with the rules and regulations of the Commodity Futures Trading Commission (CFTC). Pursuant to amendments by the CFTC to Rule 4.5 under the Commodity Exchange Act (CEA), the Adviser has filed a notice of exemption from registration as a “commodity pool operator” with respect to the Fund. The Fund and the Adviser are therefore not subject to registration or regulation as a commodity pool operator under the CEA. In addition, certain trading restrictions are now applicable to the Fund which permit the Fund to engage in commodity interest transactions that include (i) “bona fide hedging” transactions, as that term is defined and interpreted by the CFTC and its staff, without regard to the percentage of the Fund’s assets committed to margin and options premiums and (ii) non-bona fide hedging transactions, provided that the Fund does not enter into such non-bona fide hedging transactions if, immediately thereafter, either (a) the sum of the amount of initial margin deposits on the Fund’s existing futures positions or swaps positions and option or swaption premiums would exceed 5% of the market value of the Fund’s liquidating value, after taking into account unrealized profits and unrealized losses on any such transactions, or (b) the aggregate net notional value of the Fund’s commodity interest transactions would not exceed 100% of the market value of the Fund’s liquidating value, after taking into account unrealized profits and unrealized losses on any such transactions. Therefore, in order to claim the Rule 4.5 exemption, the Fund is limited in its ability to invest in commodity futures, options, and certain types of swaps (including securities futures, broad based stock index futures, and financial futures contracts). As a result, in the future the Fund will be more limited in its ability to use these instruments than in the past, and these limitations may have a negative impact on the ability of the Adviser to manage the Fund, and on the Fund’s performance.

Investments in Other Investment Companies. The Fund may invest, from time to time, in shares of other investment companies (or entities that would be considered investment companies but are excluded from the definition pursuant to certain exceptions under the 1940 Act) (the Acquired Funds) in accordance with the 1940

 

22


The Gabelli Equity Trust Inc.

Notes to Financial Statements (Unaudited) (Continued)

 

 

Act and related rules. Shareholders in the Fund would bear the pro rata portion of the periodic expenses of the Acquired Funds in addition to the Fund’s expenses. For the six months ended June 30, 2019, the Fund’s pro rata portion of the periodic expenses charged by the Acquired Funds was less than 1 basis point.

Foreign Currency Translations. The books and records of the Fund are maintained in U.S. dollars. Foreign currencies, investments, and other assets and liabilities are translated into U.S. dollars at current exchange rates. Purchases and sales of investment securities, income, and expenses are translated at the exchange rate prevailing on the respective dates of such transactions. Unrealized gains and losses that result from changes in foreign exchange rates and/or changes in market prices of securities have been included in unrealized appreciation/depreciation on investments and foreign currency translations. Net realized foreign currency gains and losses resulting from changes in exchange rates include foreign currency gains and losses between trade date and settlement date on investment securities transactions, foreign currency transactions, and the difference between the amounts of interest and dividends recorded on the books of the Fund and the amounts actually received. The portion of foreign currency gains and losses related to fluctuation in exchange rates between the initial purchase trade date and subsequent sale trade date is included in realized gain/(loss) on investments.

Foreign Securities. The Fund may directly purchase securities of foreign issuers. Investing in securities of foreign issuers involves special risks not typically associated with investing in securities of U.S. issuers. The risks include possible revaluation of currencies, the inability to repatriate funds, less complete financial information about companies, and possible future adverse political and economic developments. Moreover, securities of many foreign issuers and their markets may be less liquid and their prices more volatile than securities of comparable U.S. issuers.

Foreign Taxes. The Fund may be subject to foreign taxes on income, gains on investments, or currency repatriation, a portion of which may be recoverable. The Fund will accrue such taxes and recoveries as applicable, based upon its current interpretation of tax rules and regulations that exist in the markets in which it invests.

Restricted Securities. The Fund may invest up to 10% of its net assets in securities for which the markets are restricted. Restricted securities include securities whose disposition is subject to substantial legal or contractual restrictions. The sale of restricted securities often requires more time and results in higher brokerage charges or dealer discounts and other selling expenses than the sale of securities eligible for trading on national securities exchanges or in the over-the-counter markets. Restricted securities may sell at a price lower than similar securities that are not subject to restrictions on resale. Securities freely saleable among qualified institutional investors under special rules adopted by the SEC may be treated as liquid if they satisfy liquidity standards established by the Board. The continued liquidity of such securities is not as well assured as that of publicly traded securities, and, accordingly, the Board will monitor their liquidity. At June 30, 2019, the Fund held no restricted securities.

Securities Transactions and Investment Income. Securities transactions are accounted for on the trade date with realized gain/(loss) on investments determined by using the identified cost method. Interest income (including amortization of premium and accretion of discount) is recorded on an accrual basis. Premiums and discounts on debt securities are amortized using the effective yield to maturity method. Dividend income is recorded on the ex-dividend date, except for certain dividends from foreign securities that are recorded as soon after the ex-dividend date as the Fund becomes aware of such dividends.

 

23


The Gabelli Equity Trust Inc.

Notes to Financial Statements (Unaudited) (Continued)

 

 

Custodian Fee Credits and Interest Expense. When cash balances are maintained in the custody account, the Fund receives credits which are used to offset custodian fess. The gross expenses paid under the custody arrangement are included in custodian fees in the Statement of Operations with the corresponding expense offset, if any, shown as “Custodian fee credits.” When cash balances are overdrawn, the Fund is charged an overdraft fee of 110% of the 90 day U.S. Treasury Bill rate on outstanding balances. This amount, if any, would be included in the Statement of Operations.

Distributions to Shareholders. Distributions to common shareholders are recorded on the ex-dividend date. Distributions to shareholders are based on income and capital gains as determined in accordance with federal income tax regulations, which may differ from income and capital gains as determined under GAAP. These differences are primarily due to differing treatments of income and gains on various investment securities and foreign currency transactions held by the Fund, timing differences, and differing characterizations of distributions made by the Fund. Distributions from net investment income for federal income tax purposes include net realized gains on foreign currency transactions. These book/tax differences are either temporary or permanent in nature. To the extent these differences are permanent, adjustments are made to the appropriate capital accounts in the period when the differences arise. These reclassifications have no impact on the NAV of the Fund.

Under the Fund’s current common share distribution policy, the Fund declares and pays quarterly distributions from net investment income, capital gains, and paid-in capital. The actual source of the distribution is determined after the end of the year. Pursuant to this policy, distributions during the year may be made in excess of required distributions. To the extent such distributions are made from current earnings and profits, they are considered ordinary income or long term capital gains. The Fund’s current distribution policy may restrict the Fund’s ability to pass through to shareholders all of its net realized long term capital gains as a Capital Gain Dividend and may cause such gains to be treated as ordinary income. Distributions sourced from paid-in capital should not be considered as dividend yield or the total return from an investment in the Fund. The Board will continue to monitor the Fund’s distribution level, taking into consideration the Fund’s NAV and the financial market environment. The Fund’s distribution policy is subject to modification by the Board at any time.

Distributions to shareholders of the Fund’s Series C Auction Rate Cumulative Preferred Stock, 5.875% Series D Cumulative Preferred Stock, Series E Auction Rate Cumulative Preferred Stock, 5.000% Series G Cumulative Preferred Stock, 5.000% Series H Cumulative Preferred Stock, and 5.450% Series J Cumulative Preferred Stock (Preferred Stock) are recorded on a daily basis and are determined as described in Note 5.

The tax character of distributions paid during the year ended December 31, 2018 was as follows:

 

     Common      Preferred  

Distributions paid from:

     

Ordinary income (inclusive of short term capital gains)

   $ 15,785,455      $ 2,043,324  

Net long term capital gains

     136,915,175        17,722,772  

Return of capital

     8,979,028         
  

 

 

    

 

 

 

Total distributions paid

   $ 161,679,658      $ 19,766,096  
  

 

 

    

 

 

 

Provision for Income Taxes. The Fund intends to continue to qualify as a regulated investment company under Subchapter M of the Internal Revenue Code of 1986, as amended (the Code). It is the policy of the Fund to comply with the requirements of the Code applicable to regulated investment companies and to distribute

 

24


The Gabelli Equity Trust Inc.

Notes to Financial Statements (Unaudited) (Continued)

 

 

substantially all of its net investment company taxable income and net capital gains. Therefore, no provision for federal income taxes is required.

The following summarizes the tax cost of investments and the related net unrealized appreciation at June 30, 2019:

 

     Cost      Gross
Unrealized
Appreciation
     Gross
Unrealized
Depreciation
     Net Unrealized
Appreciation

Investments and derivative instruments

     $ 1,220,000,565        $ 784,884,326        $ (86,375,313 )        $ 698,509,013

The Fund is required to evaluate tax positions taken or expected to be taken in the course of preparing the Fund’s tax returns to determine whether the tax positions are “more-likely-than-not” of being sustained by the applicable tax authority. Income tax and related interest and penalties would be recognized by the Fund as tax expense in the Statement of Operations if the tax positions were deemed not to meet the more-likely-than-not threshold. During the six months ended June 30, 2019, the Fund did not incur any income tax, interest, or penalties. As of June 30, 2019, the Adviser has reviewed all open tax years and concluded that there was no impact to the Fund’s net assets or results of operations. The Fund’s federal and state tax returns for the prior three fiscal years remain open, subject to examination. On an ongoing basis, the Adviser will monitor the Fund’s tax positions to determine if adjustments to this conclusion are necessary.

3. Investment Advisory Agreement and Other Transactions. The Fund has entered into an investment advisory agreement (the Advisory Agreement) with the Adviser which provides that the Fund will pay the Adviser a fee, computed weekly and paid monthly, equal on an annual basis to 1.00% of the value of the Fund’s average weekly net assets including the liquidation value of preferred stock. In accordance with the Advisory Agreement, the Adviser provides a continuous investment program for the Fund’s portfolio and oversees the administration of all aspects of the Fund’s business and affairs.

As per the approval of the Board, the Fund compensates officers of the Fund, who are employed by the Fund and are not employed by the Adviser (although the officers may receive incentive based variable compensation from affiliates of the Adviser). During the six months ended June 30, 2019, the Fund accrued $70,780 in payroll expenses in the Statement of Operations.

The Adviser has agreed to reduce the management fee on the incremental assets attributable to the Series C, Series D, and Series E Preferred Stock (C, D, and E Preferred Stock) if the total return of the NAV of the common shares of the Fund, including distributions and advisory fee subject to reduction, does not exceed the stated dividend rate of the C, D, and E Preferred Stock for the year. The Fund’s total return on the NAV of the common shares is monitored on a monthly basis to assess whether the total return on the NAV of the common shares exceeds the stated dividend rate of the C, D, and E Preferred Stock for the period. During the six months ended June 30, 2019, the Fund’s total return on the NAV of the common shares exceeded the dividend rate of the outstanding C, D, and E Preferred Stock. Thus, advisory fees of the C, D, and E Preferred Stock were accrued.

During the six months ended June 30, 2019, the Fund paid $32,707 in brokerage commissions on security trades to G.research, LLC, an affiliate of the Adviser.

 

25


The Gabelli Equity Trust Inc.

Notes to Financial Statements (Unaudited) (Continued)

 

 

During the six months ended June 30, 2019, the Fund received credits from a designated broker who agreed to pay certain Fund operating expenses. The amount of such expenses paid through this directed brokerage arrangement during this period was $7,441.

The cost of calculating the Fund’s NAV per share is a Fund expense pursuant to the Advisory Agreement between the Fund and the Adviser. Under the sub-administration agreement with Bank of New York Mellon, the fees paid include the cost of calculating the Fund’s NAV. The Fund reimburses the Adviser for this service. During the six months ended June 30, 2019, the Fund accrued $22,500 in accounting fees in the Statement of Operations.

There was a reduction in the advisory fee paid to the Adviser relating to certain portfolio holdings, i.e., unsupervised assets, of the Fund with respect to which the Adviser transferred dispositive and voting control to the Fund’s Proxy Voting Committee. During the six months ended June 30, 2019, the Fund’s Proxy Voting Committee exercised control and discretion over all rights to vote or consent with respect to such securities, and the Adviser reduced its fee with respect to such securities by $2,307.

The Fund pays each Director who is not considered an affiliated person an annual retainer of $15,000 plus $2,000 for each Board meeting attended. Each Director is reimbursed by the Fund for any out of pocket expenses incurred in attending meetings. All Board committee members receive $1,000 per meeting attended. The Audit Committee Chairman receives an annual fee of $3,000, and the Nominating Committee Chairman and the Lead Director each receives an annual fee of $2,000. A Director may receive a single meeting fee, allocated among the participating funds, for participation in certain meetings held on behalf of multiple funds. Directors who are directors or employees of the Adviser or an affiliated company receive no compensation or expense reimbursement from the Fund.

The Fund engaged in a purchase transaction with a fund that has a common investment adviser. This purchase transaction complied with Rule 17a-7 under the Act and amounted to $856,900.

4. Portfolio Securities. Purchases and sales of securities during the six months ended June 30, 2019, other than short term securities and U.S. Government obligations, aggregated $58,253,089 and $109,358,455, respectively.

5. Capital. The Fund’s Articles of Incorporation, as amended, permit the Fund to issue 337,024,900 shares of common stock (par value $0.001) and authorizes the Board to increase its authorized shares from time to time. The Board has authorized the repurchase of its shares on the open market when the shares are trading on the NYSE at a discount of 10% or more (or such other percentage as the Board may determine from time to time) from the NAV of the shares. During the six months ended June 30, 2019 and the year ended December 31, 2018, the Fund did not repurchase any shares of its common stock in the open market.

 

26


The Gabelli Equity Trust Inc.

Notes to Financial Statements (Unaudited) (Continued)

 

 

Transactions in shares of common stock were as follows:

 

     Six Months Ended
June 30, 2019
(Unaudited)
   Year Ended
December 31, 2018
     Shares    Amount    Shares    Amount

Increase from common shares issued upon reinvestment of distributions

       1,857,733      $ 10,873,445        1,225,559      $ 7,658,026

The Fund has an effective shelf registration authorizing the offering of an additional $500 million of common or preferred shares. As of June 30, 2019, the Fund has approximately $327 million available for issuance under the current shelf registration.

The Fund’s Articles of Incorporation, as amended, authorize the issuance of up to 18,000,000 shares of $0.001 par value Preferred Stock. The Preferred Stock is senior to the common stock and results in the financial leveraging of the common stock. Such leveraging tends to magnify both the risks and opportunities to common shareholders. Dividends on shares of the Preferred Stock are cumulative. The Fund is required by the 1940 Act and by the Fund’s Articles Supplementary to meet certain asset coverage tests with respect to the Preferred Stock. If the Fund fails to meet these requirements and does not correct such failure, the Fund may be required to redeem, in part or in full, the Series C, Series D, Series E, Series G, Series H, and Series J Preferred Stock at redemption prices of $25,000, $25, $25,000, $25, $25, and $25, respectively, per share plus an amount equal to the accumulated and unpaid dividends whether or not declared on such shares in order to meet these requirements. Additionally, failure to meet the foregoing asset coverage requirements could restrict the Fund’s ability to pay dividends to common shareholders and could lead to sales of portfolio securities at inopportune times. The income received on the Fund’s assets may vary in a manner unrelated to the fixed and variable rates, which could have either a beneficial or detrimental impact on net investment income and gains available to common shareholders.

For Series C and Series E Preferred Stock, the dividend rates, as set by the auction process that is generally held every seven days, are expected to vary with short term interest rates. Since February 2008, the number of shares of Series C and Series E Preferred Stock subject to bid orders by potential holders has been less than the number of shares of Series C and Series E Preferred Stock subject to sell orders. Holders that have submitted sell orders have not been able to sell any or all of the Series C and Series E Preferred Stock for which they have submitted sell orders. Therefore, the weekly auctions have failed, and the dividend rate has been the maximum rate. For Series C and Series E Preferred Stock, the maximum auction rate is 175% of the “AA” Financial Composite Commercial Paper Rate. Existing Series C and Series E shareholders may submit an order to hold, bid, or sell such shares on each auction date, or trade their shares in the secondary market.

The Fund may redeem at any time, in whole or in part, the Series C, Series D, Series E, Series G, and Series H Preferred Stock at their respective liquidation prices plus any accrued and unpaid dividends. In addition, the Board has authorized the repurchase of the Series J Preferred Stock in the open market at a price less than the $25 liquidation value per share. During the six months ended June 30, 2019 and the year ended December 31, 2018, the Fund did not repurchase or redeem any shares of Series C, Series D, Series E, Series G, Series H, and Series J Preferred Stock.

The Fund has the authority to purchase its auction rate Series C and Series E preferred shares through negotiated private transactions. The Fund is not obligated to purchase any dollar amount or number of auction rate preferred

 

27


The Gabelli Equity Trust Inc.

Notes to Financial Statements (Unaudited) (Continued)

 

 

shares, and the timing and amount of any auction rate preferred shares purchased will depend on market conditions, share price, capital availability, and other factors. The Fund is not soliciting holders to sell these shares nor recommending that holders offer them to the Fund. Any offers can be accepted or rejected in the Fund’s discretion.

The following table summarizes Cumulative Preferred Stock information:

 

Series   Issue Date   Authorized   Number of Shares
Outstanding at
06/30/19
  Net Proceeds   2019 Dividend
Rate Range
  Dividend
Rate at
06/30/19
  Accrued
Dividends at
06/30/19

C Auction Rate

      June 27, 2002       5,200       2,880     $ 128,246,557   4.079% to 4.360%       4.079 %     $ 40,231

D 5.875%

      October 7, 2003       3,000,000       2,363,860     $ 72,375,842   Fixed Rate       5.875 %     $ 48,221

E Auction Rate

      October 7, 2003       2,000       1,120     $ 49,350,009   4.079% to 4.360%       4.184 %     $ 9,629

G 5.000%

      August 1, 2012       3,280,477       2,779,796     $ 69,407,417   Fixed Rate       5.000 %     $ 48,260

H 5.000%

      September 28, 2012       4,198,880       4,172,873     $ 100,865,695   Fixed Rate       5.000 %     $ 72,446

J 5.450%

      March 28, 2016       4,500,000       3,200,000     $ 77,212,332   Fixed Rate       5.450 %     $ 60,556

The holders of Preferred Stock generally are entitled to one vote per share held on each matter submitted to a vote of shareholders of the Fund and will vote together with holders of common stock as a single class. The holders of Preferred Stock voting together as a single class also have the right currently to elect two Directors and, under certain circumstances, are entitled to elect a majority of the Board of Directors. In addition, the affirmative vote of a majority of the votes entitled to be cast by holders of all outstanding shares of the preferred stock, voting as a single class, will be required to approve any plan of reorganization adversely affecting the preferred stock, and the approval of two-thirds of each class, voting separately, of the Fund’s outstanding voting stock must approve the conversion of the Fund from a closed-end to an open-end investment company. The approval of a majority (as defined in the 1940 Act) of the outstanding preferred stock and a majority (as defined in the 1940 Act) of the Fund’s outstanding voting securities are required to approve certain other actions, including changes in the Fund’s investment objectives or fundamental investment policies.

6. Indemnifications. The Fund enters into contracts that contain a variety of indemnifications. The Fund’s maximum exposure under these arrangements is unknown. However, the Fund has not had prior claims or losses pursuant to these contracts. Management has reviewed the Fund’s existing contracts and expects the risk of loss to be remote.

7. Subsequent Events. Management has evaluated the impact on the Fund of all subsequent events occurring through the date the financial statements were issued and has determined that there were no subsequent events requiring recognition or disclosure in the financial statements.

 

28


The Gabelli Equity Trust Inc.

Notes to Financial Statements (Unaudited) (Continued)

 

 

Certifications

The Fund’s Chief Executive Officer has certified to the New York Stock Exchange (NYSE) that, as of June 10, 2019, he was not aware of any violation by the Fund of applicable NYSE corporate governance listing standards. The Fund reports to the SEC on Form N-CSR which contains certifications by the Fund’s principal executive officer and principal financial officer that relate to the Fund’s disclosure in such reports and that are required by Rule 30a-2(a) under the 1940 Act.

Shareholder Meeting – May 13, 2019 – Final Results

The Fund’s Annual Meeting of Shareholders was held on May 13, 2019, in Greenwich, Connecticut. At that meeting, common and preferred shareholders, voting together as a single class, re-elected Mario J. Gabelli and William F. Heitmann as Directors of the Fund, with 208,188,447 votes and 228,003,409 votes cast in favor of these Directors, and 24,152,779 votes and 4,337,817 votes withheld for these Directors, respectively.

James P. Conn, Frank J. Fahrenkopf, Jr., Michael J. Ferrantino, Kuni Nakamura, and Salvatore J. Zizza continue to serve in their capacities as Directors of the Fund.

We thank you for your participation and appreciate your continued support.

 

29


The Gabelli Equity Trust Inc.

Board Consideration and Re-Approval of Investment Advisory Agreement (Unaudited)

Section 15(c) of the Investment Company Act of 1940, as amended (the 1940 Act), contemplates that the Board of Directors (the Board) of The Gabelli Equity Trust Inc. (the Fund), including a majority of the Directors who have no direct or indirect interest in the investment advisory agreement and are not “interested persons” of the Fund, as defined in the 1940 Act (the Independent Board Members), are required to annually review and re-approve the terms of the Fund’s existing investment advisory agreement and approve any newly proposed terms therein. In this regard, the Board reviewed and re-approved, during the most recent six month period covered by this report, the Investment Advisory Agreement (the Advisory Agreement) with Gabelli Funds, LLC (the Adviser) for the Fund.

More specifically, at a meeting held on May 15, 2019, the Board, including the Independent Board Members, considered the factors and reached the conclusions described below relating to the selection of the Adviser and the re-approval of the Advisory Agreement.

Nature, Extent, and Quality of Services.

The Independent Board Members considered information regarding the portfolio managers, the depth of the analyst pool available to the Adviser and the portfolio managers, the nature, quality and extent of administrative and shareholder services supervised or provided by the Adviser, including portfolio management, supervision of Fund operations and compliance and regulatory filings and disclosures to shareholders, general oversight of other service providers, review of Fund legal issues, assisting the Independent Board Members in their capacity as directors, and other services, and the absence of significant service problems reported to the Board. The Independent Board Members concluded that the services are extensive in nature and that the Adviser consistently delivered a high level of service.

Investment Performance of the Fund and Adviser.

The Independent Board Members considered short term and long term investment performance for the Fund over various periods of time as compared with relevant equity indices and the performance of other core, growth, and value equity closed-end funds included in the Broadridge peer category. The Board noted that the Fund’s total return performance was above the average and median of a select group of peers and the Fund’s Broadridge peer group category for the three, five and ten year periods ended March 31, 2019 and below the average and median for the Broadridge peer group for the one year period. The Independent Board Members concluded that the Adviser was delivering satisfactory performance results consistent with the investment strategies being pursued by the Fund and disclosed to investors.

Costs of Services and Profits Realized by the Adviser.

(a) Costs of Services to Fund: Fees and Expenses. The Independent Board Members considered the Fund’s advisory fee rate and expense ratio relative to industry averages for the Fund’s Broadridge peer group category and the advisory fees charged by the Adviser and its affiliates to other fund and non-fund clients. The Independent Board Members noted that the mix of services under the Advisory Agreement is much more extensive than those under the advisory agreements for non-fund clients. The Independent Board Members noted that the “other non-advisory expenses” paid by the Fund are in line with the average and above the median for the Fund’s Broadridge peer group category and below the average and median for a select group of peers, and that management and gross advisory fees and total expenses were above the average and median of the Broadridge peer group range and a select group of peers. They took note of the fact that the use of leverage

 

30


The Gabelli Equity Trust Inc.

Board Consideration and Re-Approval of Investment Advisory Agreement (Unaudited) (Continued)

 

impacts comparative expenses to peer funds, not all of which utilize leverage. The Independent Board Members were aware that the Adviser waives its fee on the incremental liquidation value of the Fund’s Series C, Series D, and Series E Preferred Stock if the total return on NAV of the common stock does not exceed the stated dividend rate for the Series C, Series D, and Series E Preferred Stock, as applicable, for the year after consideration of the reinvestment of distributions and the advisory fees attributable to the incremental liquidation value of the Series C, Series D, and Series E Preferred Stock, and that the comparative “total expense ratio” and “other expense” information reflected these waivers, if applicable. The Independent Board Members concluded that the fee is acceptable based upon the qualifications, experience, reputation, and performance of the Adviser and other factors considered.

(b) Profitability and Costs of Services to Adviser.

The Independent Board Members considered the Adviser’s overall profitability and costs. The Independent Board Members referred to the Board Materials for the pro forma income statements for the Adviser and the Fund for the period ended December 31, 2018. They noted the pro forma estimates of the Adviser’s profitability and costs attributable to the Fund, both as part of the Fund Complex and under the assumption that the Fund constituted the Adviser’s only investment company under its management. The Independent Board Members also considered whether the amount of profit is a fair entrepreneurial profit for the management of the Fund and noted that the Adviser continues to substantially increase its resources devoted to Fund matters in response to regulatory requirements and new or enhanced Fund policies and procedures. The Independent Board Members concluded that the absolute advisory fee was not excessive despite the absence of breakpoints, particularly in light of the above-average performance over time.

Extent of Economies of Scale as Fund Grows.

The Independent Board Members considered whether there have been economies of scale with respect to the management of the Fund and whether the Fund has appropriately benefited from any economies of scale. The Independent Board Members noted that, although the ability of the Fund to realize economies of scale through growth is more limited than for an open-end fund, economies of scale may develop for certain funds as their assets increase and their fund level expenses decline as a percentage of assets, but that fund level economies of scale may not necessarily result in Adviser level economies of scale. The Independent Board Members were aware that economies can be shared through an adviser’s investment in its fund advisory business and noted the Adviser’s increase in personnel and resources devoted to the Gabelli/GAMCO fund complex in recent years, which could benefit the Fund.

Whether Fee Levels Reflect Economies of Scale.

The Independent Board Members also considered whether the advisory fee rate is reasonable in relation to the asset size of the Fund and any economies of scale that may exist, and concluded that the Fund’s current fee schedule (without breakpoints) was considered reasonable, particularly in light of the Fund’s above-average performance over time.

Other Relevant Considerations.

(a) Adviser Personnel and Methods. The Independent Board Members considered the size, education, and experience of the Adviser’s staff, the Adviser’s fundamental research capabilities, and the Adviser’s approach to recruiting, training, and retaining portfolio managers and other research and management personnel and

 

31


The Gabelli Equity Trust Inc.

Board Consideration and Re-Approval of Investment Advisory Agreement (Unaudited) (Continued)

 

concluded that, in each of these areas, the Adviser was structured in such a way to support the high level of services being provided to the Fund.

(b) Other Benefits to the Adviser. The Independent Board Members also considered the character and amount of other incidental benefits received by the Adviser and its affiliates from its association with the Fund. The Independent Board Members considered the brokerage commissions paid to an affiliate of the Adviser. The Independent Board Members concluded that potential “fall-out” benefits that the Adviser and its affiliates may receive, such as brokerage commissions paid to an affiliated broker, greater name recognition, or increased ability to obtain research services, appear to be reasonable and may in some cases benefit the Fund.

Conclusions

In considering the Advisory Agreement, the Independent Board Members did not identify any factor as all-important or all-controlling, and instead considered these factors collectively in light of the Fund’s surrounding circumstances. Based on this review, it was the judgment of the Independent Board Members that shareholders had received satisfactory absolute and relative performance over time consistent with the investment strategies being pursued by the Fund at reasonable fees and, therefore, continuation of the Advisory Agreement was in the best interests of the Fund and its shareholders. As a part of its decision making process, the Independent Board Members noted that the Adviser has managed the Fund since its inception, and the Independent Board Members believe that a long term relationship with a capable, conscientious adviser is in the best interests of the Fund. The Independent Board Members considered, generally, that shareholders invested in the Fund knowing that the Adviser managed the Fund and knowing its investment advisory fee. As such, the Independent Board Members considered, in particular, whether the Adviser managed the Fund in accordance with its investment objectives and policies as disclosed to shareholders. The Independent Board Members concluded that the Fund was managed by the Adviser in a manner consistent with its investment objectives and policies. The Independent Board Members also confirmed that they were satisfied with the information provided by the Adviser, that it included all information the Independent Board Members believed was necessary to evaluate the terms of the Advisory Agreement, and that the Independent Board Members were satisfied that any questions they had were appropriately addressed. On the basis of the foregoing and without assigning particular weight to any single conclusion, the Independent Board Members determined to recommend continuation of the Advisory Agreement to the full Board.

Based on a consideration of all these factors in their totality, the Board Members present at the Meeting, including all of the Independent Board Members, determined that the Fund’s advisory fee was fair and reasonable with respect to the nature and quality of services provided and in light of the other factors described above that the Board deemed relevant. Accordingly, the Board Members determined to approve the continuation of the Fund’s Advisory Agreement. The Board Members based their decision on evaluations of all these factors as a whole and did not consider any one factor as all-important or controlling.

 

32


 

This page was intentionally left blank.

 

 

 


THE GABELLI EQUITY TRUST INC.

One Corporate Center

Rye, NY 10580-1422

Portfolio Management Team Biographies

 

LOGO  

Mario J. Gabelli, CFA, is Chairman, Chief Executive Officer, and Chief Investment Officer - Value Portfolios of GAMCO Investors, Inc. that he founded in 1977, and Chief Investment Officer - Value Portfolios of Gabelli Funds, LLC and GAMCO Asset Management Inc. He is also Executive Chairman of Associated Capital Group, Inc. Mr. Gabelli is a summa cum laude graduate of Fordham University and holds an MBA degree from Columbia Business School and Honorary Doctorates from Fordham University and Roger Williams University.

LOGO  

Christopher J. Marangi joined Gabelli in 2003 as a research analyst. Currently he is a Managing Director and Co-Chief Investment Officer for GAMCO Investors, Inc.’s Value team. In addition, he serves as a portfolio manager of Gabelli Funds, LLC and manages several funds within the Gabelli/GAMCO Fund Complex. Mr. Marangi graduated magna cum laude and Phi Beta Kappa with a BA in Political Economy from Williams College and holds an MBA degree with honors from Columbia Business School.

LOGO  

Kevin V. Dreyer joined Gabelli in 2005 as a research analyst covering companies within the consumer sector. Currently he is a Managing Director and Co-Chief Investment Officer for GAMCO Investors, Inc.’s Value team. In addition, he serves as a portfolio manager of Gabelli Funds, LLC and manages several funds within the Gabelli/GAMCO Fund Complex. Mr. Dreyer received a BSE from the University of Pennsylvania and an MBA degree from Columbia Business School.


LOGO   

Robert D. Leininger, CFA, joined GAMCO Investors, Inc. in 1993 as an equity analyst. Subsequently, he was a partner and portfolio manager at Rorer Asset Management before rejoining GAMCO in 2010 where he currently serves as a portfolio manager of Gabelli Funds, LLC. Mr. Leininger is a magna cum laude graduate of Amherst College with a degree in Economics and holds an MBA degree from the Wharton School at the University of Pennsylvania.

LOGO   

Daniel M. Miller has been the portfolio manager of The Gabelli Focus Five Fund since inception of the investment strategy on January 1, 2012. He is also a Managing Director of GAMCO Investors, Inc. Mr. Miller joined the Firm in 2002 and graduated magna cum laude with a degree in finance from the University of Miami in Coral Gables, Florida.

LOGO   

Jennie Tsai joined Gabelli in 2001 as a research analyst responsible for the healthcare and medical products industries. At Gabelli, Ms. Tsai is focused on medical sectors, including dental, orthopedics, diagnostics, dermatology, and ophthalmology. She received a BS in Commerce at the University of Virginia and an MBA from Columbia Business School.

The Net Asset Value per share appears in the Publicly Traded Funds column, under the heading “General Equity Funds,” in Monday’s The Wall Street Journal. It is also listed in Barron’s Mutual Funds/Closed End Funds section under the heading “General Equity Funds.”

The Net Asset Value per share may be obtained each day by calling (914) 921-5070 or visiting www.gabelli.com.

The NASDAQ symbol for the Net Asset Value is “XGABX.”

 

Notice is hereby given in accordance with Section 23(c) of the Investment Company Act of 1940, as amended, that the Fund may, from time to time, purchase its common shares in the open market when the Fund’s shares are trading at a discount of 10% or more from the net asset value of the shares. The Fund may also, from time to time, purchase its preferred shares in the open market when the preferred shares are trading at a discount to the liquidation value.


THE GABELLI EQUITY TRUST INC.

One Corporate Center

Rye, NY 10580-1422

t   800-GABELLI (800-422-3554)

f   914-921-5118

e   info@gabelli.com

 GABELLI.COM

 

 

DIRECTORS

 

  

 

OFFICERS

 

Mario J. Gabelli, CFA

Chairman and

Chief Executive Officer,

GAMCO Investors, Inc.

Executive Chairman,

Associated Capital Group, Inc.

 

James P. Conn

Former Managing Director &

Chief Investment Officer,

Financial Security Assurance

Holdings Ltd.

 

Frank J. Fahrenkopf, Jr.

Former President &

Chief Executive Officer,

American Gaming Association

 

Michael J. Ferrantino

Chief Executive Officer,

InterEx, Inc.

 

William F. Heitmann

Former Senior Vice President

of Finance,

Verizon Communications, Inc.

 

Kuni Nakamura

President,

Advanced Polymer, Inc.

 

Salvatore J. Zizza

Chairman,

Zizza & Associates Corp.

 

  

Bruce N. Alpert

President

 

John C. Ball

Treasurer

 

Agnes Mullady

Vice President

 

Andrea R. Mango

Secretary & Vice President

 

Richard J. Walz

Chief Compliance Officer

 

Molly A.F. Marion

Vice President & Ombudsman

 

Carter W. Austin

Vice President

 

David I. Schachter

Vice President

 

INVESTMENT ADVISER

 

Gabelli Funds, LLC

One Corporate Center

Rye, New York 10580-1422

 

CUSTODIAN

 

The Bank of New York Mellon

 

COUNSEL

 

Willkie Farr & Gallagher LLP

 

TRANSFER AGENT AND

REGISTRAR

 

Computershare Trust Company, N.A.

 

 

GAB Q2/2019     

LOGO

 


Item 2. Code of Ethics.

Not applicable.

 

Item 3.

Audit Committee Financial Expert.

Not applicable.

 

Item 4.

Principal Accountant Fees and Services.

Not applicable.

 

Item 5.

Audit Committee of Listed Registrants.

Not applicable.

 

Item 6.

Investments.

 

(a)

Schedule of Investments in securities of unaffiliated issuers as of the close of the reporting period is included as part of the report to shareholders filed under Item 1 of this form.

 

(b)

Not applicable.

 

Item 7.

Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.

Not applicable.

 

Item 8.

Portfolio Managers of Closed-End Management Investment Companies.


There has been no change, as of the date of this filing, in any of the portfolio managers identified in response to paragraph (a)(1) of this Item in the registrant’s most recently filed annual report on Form N-CSR.

 

Item 9.

Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.

REGISTRANT PURCHASES OF EQUITY SECURITIES

 

Period

 

 

(a) Total Number of
Shares (or Units)
Purchased)

 

 

(b) Average Price
Paid per Share (or
Unit)

 

  

(c) Total Number of
Shares (or Units)
Purchased as Part of
Publicly Announced
Plans or Programs

 

  

(d) Maximum Number (or
Approximate Dollar Value) of
Shares (or Units) that May Yet be
Purchased Under the Plans or
Programs

 

Month #1
01/01/2019 through 01/31/2019

 

 

Common – N/A

 

Preferred Series D –

N/A

 

Preferred Series G –

N/A

 

Preferred Series H –

N/A

 

Preferred Series J –

N/A

 

 

Common – N/A

 

Preferred Series D –

N/A

 

Preferred Series G –

N/A

 

Preferred Series H –

N/A

 

Preferred Series J –
N/A

 

  

Common – N/A

 

Preferred Series D –

N/A

 

Preferred Series G –

N/A

 

Preferred Series H –

N/A

 

Preferred Series J –

N/A

 

  

Common – 253,338,023

 

Preferred Series D – 2,363,860

 

Preferred Series G – 2,779,796

 

Preferred Series H – 4,172,873

 

Preferred Series J – 3,200,000

Month #2
02/01/2019 through 02/28/2019

 

 

Common – N/A

 

Preferred Series D –

N/A

 

Preferred Series G –

N/A

 

Preferred Series H –

N/A

 

Preferred Series J –

N/A

 

 

Common – N/A

 

Preferred Series D –

N/A

 

Preferred Series G –

N/A

 

Preferred Series H –

N/A

 

Preferred Series J –

N/A

 

  

Common – N/A

 

Preferred Series D –

N/A

 

Preferred Series G –

N/A

 

Preferred Series H –

N/A

 

Preferred Series J –

N/A

 

  

Common – 253,338,023

 

Preferred Series D – 2,363,860

 

Preferred Series G – 2,779,796

 

Preferred Series H – 4,172,873

 

Preferred Series J – 3,200,000

Month #3
03/01/2019 through 03/31/2019

 

 

Common – N/A

 

Preferred Series D –

N/A

 

Preferred Series G –

N/A

 

Preferred Series H –

N/A

 

Preferred Series J –

 

Common – N/A

 

Preferred Series D –

N/A

 

Preferred Series G –

N/A

 

Preferred Series H –

N/A

 

Preferred Series J –

  

Common – N/A

 

Preferred Series D –

N/A

 

Preferred Series G –

N/A

 

Preferred Series H –

N/A

 

Preferred Series J –

  

Common – 254,256,812

 

Preferred Series D – 2,363,860

 

Preferred Series G – 2,779,796

 

Preferred Series H – 4,172,873

 

Preferred Series J – 3,200,000


    N/A   N/A    N/A     

Month #4

04/01/2019

through

04/30/2019

 

 

Common – N/A

 

Preferred Series D –

N/A

 

Preferred Series G –

N/A

 

Preferred Series H –

N/A

 

Preferred Series J –

N/A

 

 

Common – N/A

 

Preferred Series D –

N/A

 

Preferred Series G –

N/A

 

Preferred Series H –

N/A

 

Preferred Series J –

N/A

 

  

Common – N/A

 

Preferred Series D –

N/A

 

Preferred Series G –

N/A

 

Preferred Series H –

N/A

 

Preferred Series J –

N/A

 

  

Common –254,256,812

 

Preferred Series D – 2,363,860

 

Preferred Series G – 2,779,796

 

Preferred Series H – 4,172,873

 

Preferred Series J – 3,200,000

Month #5

05/01/2019

through

05/31/2019

 

 

Common – N/A

 

Preferred Series D –

N/A

 

Preferred Series G –

N/A

 

Preferred Series H –

N/A

 

Preferred Series J –

N/A

 

 

Common – N/A

 

Preferred Series D –

N/A

 

Preferred Series G –

N/A

 

Preferred Series H –

N/A

 

Preferred Series J –

N/A

 

  

Common – N/A

 

Preferred Series D –

N/A

 

Preferred Series G –

N/A

 

Preferred Series H –

N/A

 

Preferred Series J –

N/A

 

  

Common – 254,256,812

 

Preferred Series D – 2,363,860

 

Preferred Series G – 2,779,796

 

Preferred Series H – 4,172,873

 

Preferred Series J – 3,200,000

Month #6

06/01/2019    

through

06/30/2019

 

 

Common – N/A

 

Preferred Series D –

N/A

 

Preferred Series G –

N/A

 

Preferred Series H –

N/A

 

Preferred Series J –

N/A

 

 

Common – N/A

 

Preferred Series D –

N/A

 

Preferred Series G –

N/A

 

Preferred Series H –

N/A

 

Preferred Series J –

N/A

 

  

Common – N/A

 

Preferred Series D –

N/A

 

Preferred Series G –

N/A

 

Preferred Series H –

N/A

 

Preferred Series J –

N/A

 

  

Common – 255,195,756

 

Preferred Series D – 2,363,860

 

Preferred Series G – 2,779,796

 

Preferred Series H – 4,172,873

 

Preferred Series J – 3,200,000

Total

 

 

Common – N/A

 

Preferred Series D –

N/A

 

Preferred Series G –

N/A

 

Preferred Series H –

N/A

 

Preferred Series J –

 

Common – N/A

 

Preferred Series D –

N/A

 

Preferred Series G –

N/A

 

Preferred Series H –

N/A

 

Preferred Series J –

  

Common – N/A

 

Preferred Series D –

N/A

 

Preferred Series G –

N/A

 

Preferred Series H –

N/A

 

Preferred Series J –

  

N/A

 


      

N/A

 

 

N/A

 

  

N/A

 

    

Footnote columns (c) and (d) of the table, by disclosing the following information in the aggregate for all plans or programs publicly announced:

 

a.

The date each plan or program was announced – The notice of the potential repurchase of common and preferred shares occurs semiannually in the Fund’s shareholder reports in accordance with Section 23(c) of the Investment Company Act of 1940, as amended.

b.

The dollar amount (or share or unit amount) approved – Any or all common shares outstanding may be repurchased when the Fund’s common shares are trading at a discount of 10% or more from the net asset value of the shares. Any or all preferred shares outstanding may be repurchased when the Fund’s preferred shares are trading at a discount to the liquidation value.

c.

The expiration date (if any) of each plan or program – The Fund’s repurchase plans are ongoing.

d.

Each plan or program that has expired during the period covered by the table – The Fund’s repurchase plans are ongoing.

e.

Each plan or program the registrant has determined to terminate prior to expiration, or under which the registrant does not intend to make further purchases. – The Fund’s repurchase plans are ongoing.

 

Item 10.

Submission of Matters to a Vote of Security Holders.

There have been no material changes to the procedures by which the shareholders may recommend nominees to the registrant’s Board of Directors, where those changes were implemented after the registrant last provided disclosure in response to the requirements of Item 407(c)(2)(iv) of Regulation S-K (17 CFR 229.407) (as required by Item 22(b)(15) of Schedule 14A (17 CFR 240.14a-101)), or this Item.

 

Item 11.

Controls and Procedures.

 

  (a)

The registrant’s principal executive and principal financial officers, or persons performing similar functions have concluded that the registrant’s disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940, as amended (the “1940 Act”)) are effective as of a date within 90 days of the filing of this report that includes the disclosure required by this paragraph, based on the evaluation of these controls and procedures required by Rule 30a-3(b) under the 1940 Act and Rule 15d-15(b) under the Securities Exchange Act of 1934, as amended.

 

  (b)

The registrant’s certifying officers are not aware of any changes in the registrant’s internal control over financial reporting (as defined in rule 30a-3(d) under the 1940 Act) that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.


Item 12.

Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.

 

      

Not applicable.

 

Item 13.  Exhibits.

 

  (a)(1)

Not applicable.

 

  (a)(2)

Certifications pursuant to Rule 30a-2(a) under the 1940 Act and Section 302 of the Sarbanes-Oxley Act of 2002 are attached hereto.

 

  (a)(3)

Not applicable.

 

  (a)(4)

Not applicable.

 

  (b)

Certifications pursuant to Rule 30a-2(b) under the 1940 Act and Section 906 of the Sarbanes- Oxley Act of 2002 are attached hereto.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

(Registrant)    The Gabelli Equity Trust Inc.                                                                     

By (Signature and Title)*        /s/ Bruce N. Alpert                                                             

                                                  Bruce N. Alpert, Principal Executive Officer

Date    9/5/19                                                                                                                      

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

By (Signature and Title)*        /s/ Bruce N. Alpert                                                               

                                                  Bruce N. Alpert, Principal Executive Officer

Date    9/5/19                                                                                                                         

By (Signature and Title)*       /s/ John C. Ball                                                                     

                                                  John C. Ball, Principal Financial Officer and Treasurer

Date     9/5/19                                                                                                                       

* Print the name and title of each signing officer under his or her signature.